High-purity steviol glycoside
Patent Information
- Application Number
- JP2024076669
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-02-15
- Filing Date
- 2024-05-09
- Publication Date
- 2024-11-07
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for preparing steviol glycosides from Stevia rebaudiana are unsuitable for commercial use, lacking simplicity, efficiency, and economy.
A biocatalytic process using microbial cells or enzyme preparations to convert organic substrates into target steviol glycosides, employing enzymes such as UDP-glucosyltransferases to add glucose units to steviol, with optional UDP-glucose recycling and transglycosidation using transglycosidases.
Produces highly purified steviol glycosides with yields exceeding 80-99% purity, suitable for use in consumable products as sweeteners and flavor modifiers.
Abstract
Description
[Technical field]
[0001] The present invention relates to processes for preparing compositions containing steviol glycosides, including highly purified steviol glycoside compositions. [Background technology]
[0002] 2. Background of the Invention High-intensity sweeteners have a sweetness level several times higher than that of sucrose.High-intensity sweeteners are essentially non-caloric and are commonly used in diet products and low-calorie products, including food and beverages.High-intensity sweeteners do not induce glycemic response, making them suitable for use in products targeted at diabetics and others who are concerned about controlling carbohydrate intake.
[0003] Steviol glycosides are a class of compounds found in the leaves of Stevia rebaudiana Bertoni, a perennial shrub in the Asteraceae (Compositae) family native to certain regions of South America. Steviol glycosides are structurally characterized by a single base, steviol, and differ in the presence of carbohydrate residues at the C13 and C19 positions. Steviol glycosides accumulate in Stevia leaves, constituting approximately 10%-20% of the total dry weight. On a dry weight basis, the four major glycosides found in Stevia leaves typically include stevioside (9.1%), rebaudioside A (3.8%), rebaudioside C (0.6%-1.0%), and dulcoside A (0.3%). Other known steviol glycosides include rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F and rebaudioside M, steviolbioside and rubusoside.
[0004] Methods for preparing steviol glycosides from Stevia rebaudiana are known, but many of these methods are unsuitable for commercial use.
[0005] Thus, there remains a need for simple, efficient, and economical methods of preparing compositions that contain steviol glycosides, including highly purified steviol glycoside compositions. Summary of the Invention
[0006] SUMMARY OF THE DISCLOSURE As used herein, the abbreviation "reb" refers to "rebaudioside." Both terms have the same meaning and may be used interchangeably.
[0007] As used herein, "biocatalyst" or "biocatalytic" refers to the use of naturally occurring or genetically engineered biocatalysts, such as enzymes or cells containing one or more enzymes, capable of single or multi-step chemical transformations of organic compounds. Biocatalytic processes include fermentation, biosynthesis, bioconversion and biotransformation processes. Both isolated enzyme and whole cell biocatalytic methods are known in the art. Biocatalytic protein enzymes can be naturally occurring or recombinant proteins.
[0008] As used herein, the term "steviol glycoside(s)" refers to naturally occurring steviol glycosides, such as steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside G, stevioside H, stevioside I ... Rebaudioside A, Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside Rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s, synthetic steviol glycosides, e.g., enzymatically glucosylated steviol glycosides, and combinations thereof.
[0009] As used herein, the term "SvG7" refers to any naturally occurring steviol glycoside or any synthetic steviol glycoside, including enzymatically glucosylated steviol glycosides and combinations thereof, specifically, reb 1a, reb 1b, reb 1c, reb 1d, reb 1e, reb 1f, reb 1g, reb 1h, reb 1i, reb 1j, reb 1k, reb 1l, reb 1m, reb 1n, reb 1o, reb 1p, reb 1q, reb 1r, reb 1s, reb 1t, reb 2a, reb 2b, reb 2c, reb 2d, reb2e, reb 2f, reb 2g, reb 2h, reb 2i, reb 2j, reb 2k, reb 2l, reb 2m, reb 2n, reb 2p, reb 2s, reb 2p, reb 2r, reb 2p ... SvG7 refers to a molecule comprising steviol having seven glucose residues covalently attached thereto, including, but not limited to, reb 2l, reb 2m, reb 2n, reb 2o, reb 2p, reb 2q, reb 2r, and / or reb 2s. SvG7 refers to a single steviol glycoside having seven glucose residues covalently attached thereto or a mixture of steviol glycosides having seven glucose residues covalently attached thereto.
[0010] The present invention provides a process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with microbial cells and / or an enzyme preparation, thereby producing a composition comprising the target steviol glycoside.
[0011] The starting composition can be any organic compound containing at least one carbon atom. In one embodiment, the starting composition is selected from the group consisting of steviol glycosides, polyols or sugar alcohols, and various carbohydrates.
[0012] The target steviol glycoside can be any steviol glycoside. In one embodiment, the target steviol glycoside is steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside G, rebaudioside H, rebaudioside I, rebaudioside N ... Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s, SvG7, or synthetic steviol glycoside.
[0013] In one embodiment, the target steviol glycoside is rebaudioside 1a. In one embodiment, the target steviol glycoside is rebaudioside 1b. In one embodiment, the target steviol glycoside is rebaudioside 1c. In one embodiment, the target steviol glycoside is rebaudioside 1d. In one embodiment, the target steviol glycoside is rebaudioside 1e. In one embodiment, the target steviol glycoside is rebaudioside 1f. In one embodiment, the target steviol glycoside is rebaudioside 1g. In one embodiment, the target steviol glycoside is rebaudioside 1h. In one embodiment, the target steviol glycoside is rebaudioside 1i. In one embodiment, the target steviol glycoside is rebaudioside 1j.
[0014] In one embodiment, the target steviol glycoside is rebaudioside 1k. In one embodiment, the target steviol glycoside is rebaudioside 1l. In one embodiment, the target steviol glycoside is rebaudioside 1m. In one embodiment, the target steviol glycoside is rebaudioside 1n. In one embodiment, the target steviol glycoside is rebaudioside 1o. In one embodiment, the target steviol glycoside is rebaudioside 1p. In one embodiment, the target steviol glycoside is rebaudioside 1q. In one embodiment, the target steviol glycoside is rebaudioside 1r. In one embodiment, the target steviol glycoside is rebaudioside 1s. In one embodiment, the target steviol glycoside is rebaudioside 1t.
[0015] In one embodiment, the target steviol glycoside is rebaudioside 2a. In one embodiment, the target steviol glycoside is rebaudioside 2b. In one embodiment, the target steviol glycoside is rebaudioside 2c. In one embodiment, the target steviol glycoside is rebaudioside 2d. In one embodiment, the target steviol glycoside is rebaudioside 2e. In one embodiment, the target steviol glycoside is rebaudioside 2f. In one embodiment, the target steviol glycoside is rebaudioside 2g. In one embodiment, the target steviol glycoside is rebaudioside 2h. In one embodiment, the target steviol glycoside is rebaudioside 2i. In one embodiment, the target steviol glycoside is rebaudioside 2j. In one embodiment, the target steviol glycoside is rebaudioside 2k. In one embodiment, the target steviol glycoside is rebaudioside 2l. In one embodiment, the target steviol glycoside is rebaudioside 2m. In one embodiment, the target steviol glycoside is rebaudioside 2n. In one embodiment, the target steviol glycoside is rebaudioside 2o. In one embodiment, the target steviol glycoside is rebaudioside 2p. In one embodiment, the target steviol glycoside is rebaudioside 2q. In one embodiment, the target steviol glycoside is rebaudioside 2r. In one embodiment, the target steviol glycoside is rebaudioside 2s. In one embodiment, the target steviol glycoside is rebaudioside M4. In one embodiment, the target steviol glycoside is SvG7.
[0016] In some preferred embodiments, an enzyme preparation is used that includes one or more enzymes capable of converting the starting composition to the target steviol glycosides, or microbial cells that include one or more enzymes. The enzymes may be located on the surface and / or inside the cells. The enzyme preparation may be provided in the form of a whole cell suspension, a crude lysate, or as purified enzyme(s). The enzyme preparation may be in free form or may be immobilized on a solid support made of inorganic or organic materials.
[0017] In some embodiments, the microbial cells contain the enzymes and genes encoding them necessary to convert the starting composition to the target steviol glycoside. Thus, the invention also provides a process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with microbial cells comprising at least one enzyme capable of converting the starting composition to the target steviol glycoside, thereby producing a medium comprising at least one target steviol glycoside.
[0018] Enzymes necessary to convert the starting composition to the target steviol glycosides include steviol biosynthetic enzymes, NDP-glucosyltransferase (NGT), ADP-glucosyltransferase (AGT), CDP-glucosyltransferase (CGT), GDP-glucosyltransferase (GGT), TDP-glucosyltransferase (TDP), UDP-glucosyltransferase (UGT), and / or NDP-recycling enzyme, ADP-recycling enzyme, CDP-recycling enzyme, GDP-recycling enzyme, TDP-recycling enzyme, and / or UDP-recycling enzyme.
[0019] In one embodiment, steviol biosynthetic enzymes include mevalonate (MVA) pathway enzymes.
[0020] In another embodiment, steviol biosynthetic enzymes include non-mevalonate 2-C-methyl-D-erythritol-4-phosphate pathway (MEP / DOXP) enzymes. In one embodiment, the steviol biosynthetic enzymes are geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase ( CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (HDR), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase, and the like.
[0021] The UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol and / or steviol glycoside substrates to provide the target steviol glycoside.
[0022] As used hereinafter, the term "SuSy_AT", unless otherwise specified, refers to a sucrose synthase having the amino acid sequence "SEQ ID NO:1" as described in Example 1, or a polypeptide having substantial (greater than 85%, greater than 86%, greater than 87%, greater than 88%, greater than 89%, greater than 90%, greater than 91%, greater than 92%, greater than 93%, greater than 94%, greater than 95%, greater than 96%, greater than 97%, greater than 98%, greater than 99%) amino acid sequence identity to the polypeptide of SEQ ID NO:1, as well as isolated nucleic acid molecules encoding these polypeptides.
[0023] As used hereinafter, the term "UGTSl2", unless otherwise specified, refers to a UDP-glucosyltransferase having the amino acid sequence "SEQ ID NO:2" as described in Example 1, or a polypeptide having substantial (greater than 85%, greater than 86%, greater than 87%, greater than 88%, greater than 89%, greater than 90%, greater than 91%, greater than 92%, greater than 93%, greater than 94%, greater than 95%, greater than 96%, greater than 97%, greater than 98%, greater than 99%) amino acid sequence identity to the polypeptide of SEQ ID NO:2, as well as isolated nucleic acid molecules encoding these polypeptides.
[0024] As used hereinafter, the term "UGT76G1", unless otherwise specified, refers to a UDP-glucosyltransferase having the amino acid sequence "SEQ ID NO:3" as described in Example 1, or a polypeptide having substantial (greater than 85%, greater than 86%, greater than 87%, greater than 88%, greater than 89%, greater than 90%, greater than 91%, greater than 92%, greater than 93%, greater than 94%, greater than 95%, greater than 96%, greater than 97%, greater than 98%, greater than 99%) amino acid sequence identity to the polypeptide of SEQ ID NO:3, as well as isolated nucleic acid molecules encoding these polypeptides.
[0025] In one embodiment, the steviol biosynthetic enzymes and UDP-glucosyltransferase are produced in a microbial cell. The microbial cell can be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp., etc. In another embodiment, the UDP-glucosyltransferase is synthetic.
[0026] In one embodiment, the UDP-glucosyltransferase is selected from the group including UGT74G1, UGT85C2, UGT76G1, UGT91D2, UGTSI2, EUGT11, and UGTs having substantial (greater than 85%, greater than 86%, greater than 87%, greater than 88%, greater than 89%, greater than 90%, greater than 91%, greater than 92%, greater than 93%, greater than 94%, greater than 95%, greater than 96%, greater than 97%, greater than 98%, greater than 99%) amino acid sequence identity to these polypeptides, and isolated nucleic acid molecules encoding these UGTs.
[0027] In one embodiment, the steviol biosynthetic enzymes, UGTs, and UDP-glucosyl recycling system are present in one microorganism (microbial cell). The microorganism can be, for example, Escherichia coli, Saccharomyces spp., Aspergillus spp., Pichia spp., Bacillus spp., or Yarrowia spp.
[0028] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol, or any starting steviol glycoside bearing an -OH functional group at C 13, to give a target steviol glycoside having an -O-glucose beta glucopyranoside glycosidic linkage at C 13. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0029] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol, or any starting steviol glycoside bearing a -COOH functional group at C19, to give a target steviol glycoside having a -COO-glucose beta-glucopyranoside glycosidic bond at C19. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0030] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→2 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0031] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→3 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0032] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→4 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In another specific embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0033] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→6 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0034] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→2 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0035] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→3 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0036] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→4 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In another specific embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0037] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→6 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0038] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to produce a steviol monoside, hi a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0039] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to produce steviolmonoside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0040] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to produce steviolbioside. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0041] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to produce steviolbioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1. In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to produce rubusoside. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0042] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to produce rubusoside. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0043] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to produce steviolbioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0044] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to produce steviolbioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0045] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol monoside bioside to produce rebaudioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0046] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside to produce stevioside. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0047] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to produce rebaudioside B. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0048] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to produce rebaudioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0049] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce stevioside. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0050] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce rebaudioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0051] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce stevioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0052] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce stevioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0053] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to produce stevioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0054] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to produce stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0055] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to produce stevioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0056] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to produce stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0057] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside B to produce rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0058] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to produce rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0059] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to produce rebaudioside E. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0060] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to produce rebaudioside E2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0061] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to produce rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0062] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to produce rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0063] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to produce rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0064] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to produce rebaudioside E. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0065] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to produce rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1. In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to produce rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0066] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to produce rebaudioside E2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0067] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to produce rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0068] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to produce rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0069] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to produce rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0070] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to produce rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0071] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to produce rebaudioside I. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0072] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to produce rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0073] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to produce rebaudioside AM. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0074] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to produce rebaudioside I. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0075] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to produce rebaudioside AM. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0076] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to produce rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0077] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to produce rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0078] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to produce rebaudioside I. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0079] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to produce rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0080] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to produce rebaudioside AM. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0081] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to produce rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0082] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0083] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside I to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0084] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0085] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to produce rebaudioside M4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0086] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D7 to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0087] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1a. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0088] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1b. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0089] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1c. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0090] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1d. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0091] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1e. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0092] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1f. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0093] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1g. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0094] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1h. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0095] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1i. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0096] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1j. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0097] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1k. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0098] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1l. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0099] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1m. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0100] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1n. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0101] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1o. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0102] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1p. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0103] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1q. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0104] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1r. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0105] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1s. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0106] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1t. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0107] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2a. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0108] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2b. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0109] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2c. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0110] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2d. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0111] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2e. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0112] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2f. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0113] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2g. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0114] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2h. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0115] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2i. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0116] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2j. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0117] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2k. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0118] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2l. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0119] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2m. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0120] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2n. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0121] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2o. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0122] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2p. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0123] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2q. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity with UGT76G1.
[0124] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2r. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity with UGT76G1.
[0125] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2s. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0126] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 1q. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity with UGT76G1. Optionally, the method further comprises recycling UDP to provide UDP-glucose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate such that biotranslation of steviol and / or steviol glycoside substrates to target steviol glycosides is carried out using catalytic amounts of UDP-glucosyltransferase and UDP-glucose.
[0127] In one embodiment, the recycling catalyst is sucrose synthase SuSy_At or a sucrose synthase having greater than 85% amino acid sequence identity to SuSy_At.
[0128] In one embodiment, the recycling substrate for the UDP-glucose recycling catalyst is sucrose.
[0129] Optionally, the method of the present invention further comprises the use of a transglycosidase to modify the recipient target steviol glycoside molecule using an oligosaccharide or polysaccharide as a sugar donor. Non-limiting examples include cyclodextrin glycosyltransferase (CGTase), fructofuranosidase, amylase, saccharase, glucosucrase, beta-h-fructosidase, beta-fructosidase, sucrase, fructosyl invertase, alkaline invertase, acid invertase, and fructofuranosidase. In some embodiments, sugar(s) other than glucose, including but not limited to, fructose, xylose, rhamnose, arabinose, deoxyglucose, and galactose, are translocated to the recipient target steviol glycoside. In one embodiment, the recipient steviol glycoside is rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r ... In another embodiment, the recipient steviol glycoside is rebaudioside M4, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and / or rebaudioside 2s. In another embodiment, the recipient steviol glycoside is rebaudioside M4. In another embodiment, the recipient steviol glycoside is SvG7.
[0130] Optionally, the methods of the present invention further comprise separating the target steviol glycoside from the culture medium to provide a highly purified target steviol glycoside composition. The target steviol glycoside can be separated by at least one suitable method, such as, for example, crystallization, membrane separation, centrifugation, extraction, chromatographic separation, or a combination of such methods.
[0131] In one embodiment, the target steviol glycoside can be produced in a microorganism. In another embodiment, the target steviol glycoside can be secreted into the medium. In one alternative embodiment, the released steviol glycoside can be continuously removed from the medium. In yet another embodiment, the target steviol glycoside is separated after completion of the conversion reaction.
[0132] In one embodiment, the separation produces a composition comprising greater than about 80% by weight of the target steviol glycoside on an anhydrous basis, i.e., a highly purified steviol glycoside composition. In another embodiment, the separation produces a composition comprising greater than about 90% by weight of the target steviol glycoside. In a particular embodiment, the composition comprises greater than about 95% by weight of the target steviol glycoside. In other embodiments, the composition comprises greater than about 99% by weight of the target steviol glycoside.
[0133] The target steviol glycoside may exist in any polymorphic or amorphous form, including hydrates, solvates, anhydrates, or combinations thereof.
[0134] The purified targeted steviol glycosides can be used in consumer products as sweeteners, flavor modifiers, flavor modifying properties and / or foam suppressants. Suitable consumer products include, but are not limited to, foods, beverages, pharmaceutical compositions, tobacco products, dietary supplement compositions, oral hygiene compositions, and cosmetic compositions. [Brief description of the drawings]
[0135] [Figure 1a] FIG. 1 shows the chemical structures of rebaudioside 1a of several SvG7 steviol glycosides. [Figure 1b] FIG. 1 shows the chemical structures of rebaudioside 1b of several SvG7 steviol glycosides. [Figure 1c] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1c. [Figure 1d] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1d. [Figure 1e] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1e. [Figure 1f] FIG. 1 shows the chemical structures of rebaudioside 1f of several SvG7 steviol glycosides. [Figure 1g] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides rebaudioside 1g. [Figure 1h] FIG. 1 shows the chemical structures of rebaudioside 1h of several SvG7 steviol glycosides. [Figure 1i] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1i. [Figure 1j] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1j. [Figure 1k] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1k. [Figure 1l] FIG. 1 shows the chemical structures of rebaudioside 1l of several SvG7 steviol glycosides. [Figure 1m] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1m. [Figure 1n] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides rebaudioside 1n. [Figure 1o] FIG. 1 shows the chemical structures of rebaudioside 1o of several SvG7 steviol glycosides. [Figure 1p] FIG. 1 shows the chemical structures of rebaudioside 1p of several SvG7 steviol glycosides. [Figure 1q] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1q. [Figure 1r] FIG. 1 shows the chemical structures of rebaudioside 1r of several SvG7 steviol glycosides. [Figure 1s] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1s. [Figure 1t] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 1t. [Figure 2a] FIG. 1 shows the chemical structures of rebaudioside 2a of several SvG7 steviol glycosides. [Figure 2b] FIG. 1 shows the chemical structures of rebaudioside 2b of several SvG7 steviol glycosides. [Figure 2c] FIG. 1 shows the chemical structures of rebaudioside 2c of several SvG7 steviol glycosides. [Figure 2d] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 2d. [Figure 2e] FIG. 1 shows the chemical structures of rebaudioside 2e of several SvG7 steviol glycosides. [Figure 2f] FIG. 1 shows the chemical structures of rebaudioside 2f of several SvG7 steviol glycosides. [Figure 2g] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides rebaudioside 2g. [Figure 2h] FIG. 1 shows the chemical structures of rebaudioside 2h of several SvG7 steviol glycosides. [Figure 2i] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 2i. [Figure 2j] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 2j. [Figure 2k] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 2k. [Figure 2l]FIG. 1 shows the chemical structures of rebaudioside 2l of several SvG7 steviol glycosides. [Figure 2m] FIG. 1 shows the chemical structures of rebaudioside 2m of several SvG7 steviol glycosides. [Figure 2n] FIG. 1 shows the chemical structures of rebaudioside 2n of several SvG7 steviol glycosides. [Figure 2o] FIG. 1 shows the chemical structures of rebaudioside 2o of several SvG7 steviol glycosides. [Figure 2p] FIG. 1 shows the chemical structures of rebaudioside 2p of several SvG7 steviol glycosides. [Figure 2q] FIG. 1 shows the chemical structures of several SvG7 steviol glycosides, rebaudioside 2q. [Figure 2r] FIG. 1 shows the chemical structures of rebaudioside 2r of several SvG7 steviol glycosides. [Figure 2s] FIG. 1 shows the chemical structures of rebaudioside 2s of several SvG7 steviol glycosides. [Diagram 3] FIG. 1 shows the chemical structure of Rebaudioside M4. [Figure 4a]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4b] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4c]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4d] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4e]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4f] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4g]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4h] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4i]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4j] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4k]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4l] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4m]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4n] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4o]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4p] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4q]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4r] From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 4s]From steviol and various intermediate steviol glycosides, rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t ... FIG. 1 shows pathways for producing rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and rebaudioside 2s, rebaudioside M4, and various steviol glycosides. [Figure 5a] FIG. 1 shows the biocatalytic production of rebaudioside 1a from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5b] FIG. 1 shows the biocatalytic production of rebaudioside 1b from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5c] FIG. 1 shows the biocatalytic production of rebaudioside 1c from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5d]FIG. 1 shows the biocatalytic production of rebaudioside 1d from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5e] FIG. 1 shows the biocatalytic production of rebaudioside 1e from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5f] FIG. 1 shows the biocatalytic production of rebaudioside 1f from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5g] FIG. 1 shows biocatalytic production of rebaudioside 1g from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5h] FIG. 1 shows the biocatalytic production of rebaudioside 1h from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5i] FIG. 1 shows the biocatalytic production of rebaudioside 1i from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5j] FIG. 1 shows the biocatalytic production of rebaudioside 1j from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5k]FIG. 1 shows the biocatalytic production of rebaudioside 1k from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5l] FIG. 1 shows the biocatalytic production of rebaudioside 1l from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5m] FIG. 1 shows the biocatalytic production of rebaudioside 1m from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5n] FIG. 1 shows the biocatalytic production of rebaudioside 1n from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5o] FIG. 1 shows the biocatalytic production of rebaudioside 1o from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5p] FIG. 1 shows the biocatalytic production of rebaudioside 1p from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5q] FIG. 1 shows the biocatalytic production of rebaudioside 1q from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5r]FIG. 1 shows the biocatalytic production of rebaudioside 1r from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5s] FIG. 1 shows the biocatalytic production of rebaudioside 1s from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 5t] FIG. 1 shows the biocatalytic production of rebaudioside 1t from rebaudioside A using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6a] FIG. 1 shows the biocatalytic production of rebaudioside 2a from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6b] FIG. 1 shows the biocatalytic production of rebaudioside 2b from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6c] FIG. 1 shows the biocatalytic production of rebaudioside 2c from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6d] FIG. 1 shows the biocatalytic production of rebaudioside 2d from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6e]FIG. 1 shows the biocatalytic production of rebaudioside 2e from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6f] FIG. 1 shows the biocatalytic production of rebaudioside 2f from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6g] FIG. 1 shows the biocatalytic production of rebaudioside 2g from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6h] FIG. 1 shows the biocatalytic production of rebaudioside 2h from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6i] FIG. 1 shows the biocatalytic production of rebaudioside 2i from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6j] FIG. 1 shows the biocatalytic production of rebaudioside 2j from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6k] FIG. 1 shows the biocatalytic production of rebaudioside 2k from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6l]FIG. 1 shows the biocatalytic production of rebaudioside 2l from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6m] FIG. 1 shows the biocatalytic production of rebaudioside 2m from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6n] FIG. 1 shows the biocatalytic production of rebaudioside 2n from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6o] FIG. 1 shows the biocatalytic production of rebaudioside 2o from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6p] FIG. 1 shows the biocatalytic production of rebaudioside 2p from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6q] FIG. 1 shows the biocatalytic production of rebaudioside 2q from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6r] FIG. 1 shows the biocatalytic production of rebaudioside 2r from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6s]FIG. 1 shows the biocatalytic production of rebaudioside 2s from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 6t] FIG. 1 shows the biocatalytic production of rebaudioside 1q from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 7] FIG. 1 shows the biocatalytic production of rebaudioside M4 from stevioside using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8a] FIG. 1 shows the biocatalytic production of rebaudioside 2a from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8b] FIG. 1 shows the biocatalytic production of rebaudioside 2b from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8c] FIG. 1 shows the biocatalytic production of rebaudioside 2c from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8d] FIG. 1 shows the biocatalytic production of rebaudioside 2d from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8e]FIG. 1 shows the biocatalytic production of rebaudioside 2e from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8f] FIG. 1 shows the biocatalytic production of rebaudioside 2f from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8g] FIG. 1 shows the biocatalytic production of rebaudioside 2g from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8h] FIG. 1 shows the biocatalytic production of rebaudioside 2h from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8i] FIG. 1 shows the biocatalytic production of rebaudioside 2i from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8j] FIG. 1 shows the biocatalytic production of rebaudioside 2j from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8k] FIG. 1 shows the biocatalytic production of rebaudioside 2k from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8l]FIG. 1 shows the biocatalytic production of rebaudioside 2l from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8m] FIG. 1 shows the biocatalytic production of rebaudioside 2m from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8n] FIG. 1 shows the biocatalytic production of rebaudioside 2n from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8o] FIG. 1 shows the biocatalytic production of rebaudioside 2o from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8p] FIG. 1 shows the biocatalytic production of rebaudioside 2p from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8q] FIG. 1 shows the biocatalytic production of rebaudioside 2q from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8r] FIG. 1 shows the biocatalytic production of rebaudioside 2r from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8s]FIG. 1 shows the biocatalytic production of rebaudioside 2s from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 8t] FIG. 1 shows the biocatalytic production of rebaudioside 1q from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 9] FIG. 1 shows the biocatalytic production of rebaudioside M4 from rebaudioside AM using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10a] FIG. 1 shows the biocatalytic production of rebaudioside 2a from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10b] FIG. 1 shows the biocatalytic production of rebaudioside 2b from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10c] FIG. 1 shows the biocatalytic production of rebaudioside 2c from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10d] FIG. 1 shows the biocatalytic production of rebaudioside 2d from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10e]FIG. 1 shows the biocatalytic production of rebaudioside 2e from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10f] FIG. 1 shows the biocatalytic production of rebaudioside 2f from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10g] FIG. 1 shows the biocatalytic production of rebaudioside 2g from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10h] FIG. 1 shows the biocatalytic production of rebaudioside 2h from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10i] FIG. 1 shows the biocatalytic production of rebaudioside 2i from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10j] FIG. 1 shows the biocatalytic production of rebaudioside 2j from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10k] FIG. 1 shows the biocatalytic production of rebaudioside 2k from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10l]FIG. 1 shows the biocatalytic production of rebaudioside 2l from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10m] FIG. 1 shows the biocatalytic production of rebaudioside 2m from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10n] FIG. 1 shows the biocatalytic production of rebaudioside 2n from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10o] FIG. 1 shows the biocatalytic production of rebaudioside 2o from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10p] FIG. 1 shows the biocatalytic production of rebaudioside 2p from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10q] FIG. 1 shows the biocatalytic production of rebaudioside 2q from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10r] FIG. 1 shows the biocatalytic production of rebaudioside 2r from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10s]FIG. 1 shows the biocatalytic production of rebaudioside 2s from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 10t] FIG. 1 shows the biocatalytic production of rebaudioside 1q from rebaudioside M4 using enzymes UGTSl2 and UGT76G1 and the concomitant recycling of UDP to UDP-glucose by sucrose synthase SuSy_At. [Figure 11a] 1 shows an HPLC chromatogram of stevioside. The peak at retention time 20.958 minutes corresponds to stevioside. The peak at retention time 20.725 minutes corresponds to rebaudioside A. The peak at 32.925 minutes corresponds to rebaudioside B. The peak at 33.930 minutes corresponds to steviolbioside. [Figure 11b] 1 shows an HPLC chromatogram of the products of biocatalytic production of SvG7 molecule from stevioside. The peak at 5.089 min corresponds to rebaudioside 2m. The peak at 6.459 min corresponds to rebaudioside 2a. The peak at 9.825 min corresponds to rebaudioside AM. The peak at 13.845 min corresponds to rebaudioside M. The peak at 32.974 min corresponds to rebaudioside B. The peak at 33.979 min corresponds to steviolbioside. [Figure 11c] 1 shows the HPLC chromatogram of rebaudioside 2a after purification by HPLC. The peak at retention time 6.261 minutes corresponds to rebaudioside 2a. [Figure 11d] 1 shows the HPLC chromatogram of rebaudioside 2m after purification by HPLC. The peak at retention time 5.197 minutes corresponds to rebaudioside 2m. [Figure 12a] FIG. 1 shows the 1H NMR spectrum of rebaudioside 2a (500 MHz, pyridine-d5). [Figure 12b] FIG. 1 shows the HSQC spectrum of rebaudioside 2a (500 MHz, pyridine-d5). [Figure 12c] FIG. 1 shows the H,H COSY spectrum of rebaudioside 2a (500 MHz, pyridine-d5). [Figure 12d] FIG. 1 shows the HMBC spectrum of rebaudioside 2a (500 MHz, pyridine-d5). [Figure 12e] FIG. 1 shows the HSQC-TOCSY spectrum of rebaudioside 2a (500 MHz, pyridine-d5). [Figure 12f] FIG. 1 shows the 1D-NOESY spectrum of rebaudioside 2a (500 MHz, pyridine-d5). [Figure 12g] FIG. 1 shows LC chromatogram of rebaudioside 2a. [Figure 12h] FIG. 1 shows the mass spectrum of rebaudioside 2a. [Figure 13a] FIG. 1 shows the 1H NMR spectrum of rebaudioside 2m (500 MHz, pyridine-d5). [Figure 13b] FIG. 1 shows the HSQC spectrum of rebaudioside 2m (500 MHz, pyridine-d5). [Figure 13c] FIG. 1 shows the H,H COSY spectrum of rebaudioside 2m (500 MHz, pyridine-d5). [Figure 13d] FIG. 1 shows the HMBC spectrum of rebaudioside 2m (500 MHz, pyridine-d5). [Figure 13e] FIG. 1 shows the HSQC-TOCSY spectrum of rebaudioside 2m (500 MHz, pyridine-d5). [Figure 13f] FIG. 1 shows the 1D-NOESY spectrum of rebaudioside 2m (500 MHz, pyridine-d5). [Figure 13g] FIG. 1 shows LC chromatogram of rebaudioside 2m. [Figure 13h] FIG. 1 shows the mass spectrum of rebaudioside 2m. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0136] Detailed Description The present invention also provides a process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with microbial cells and / or an enzyme preparation, thereby producing a composition comprising the target steviol glycoside.
[0137] One of the objects of the present invention is to isolate target steviol glycosides, in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, and the like, from various starting compositions. , Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1m, Rebaudioside 1mn ... Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, The present invention provides an efficient biocatalytic process for preparing rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s, and / or SvG7 or synthetic steviol glycosides.
[0138] Starting Composition As used herein, "starting composition" refers to any composition, typically an aqueous solution, that contains one or more organic compounds that contain at least one carbon atom.
[0139] In one embodiment, the starting composition is selected from the group consisting of steviol, steviol glycosides, polyols, and various carbohydrates.
[0140] The starting composition steviol glycosides are steviol, steviol monoside, steviol monoside A, steviol bioside, steviol bioside D, rubusoside, steviol bioside A, steviol bioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, and / or Rebaudioside M4 or other glycosides of steviol found in the Stevia rebaudiana plant, synthetic steviol glycosides, e.g., enzymatically glucosylated steviol glycosides, and combinations thereof.
[0141] In one embodiment, the starting composition is steviol. In another embodiment, the starting composition steviol glycoside is a steviol monoside. In yet another embodiment, the starting composition steviol glycoside is steviolmonoside A. In another embodiment, the starting composition steviol glycoside is steviolbioside. In another embodiment, the starting composition steviol glycoside is steviolbioside D. In another embodiment, the starting composition steviol glycoside is rubusoside.
[0142] In another embodiment, the starting composition steviol glycoside is rubusoside. In another embodiment, the starting composition steviol glycoside is steviolbioside A. In another embodiment, the starting composition steviol glycoside is steviolbioside B. In another embodiment, the starting composition steviol glycoside is rebaudioside B. In another embodiment, the starting composition steviol glycoside is stevioside. In another embodiment, the starting composition steviol glycoside is rebaudioside G.
[0143] In another embodiment, the starting composition steviol glycoside is stevioside A. In another embodiment, the starting composition steviol glycoside is stevioside B. In another embodiment, the starting composition steviol glycoside is stevioside C. In another embodiment, the starting composition steviol glycoside is rebaudioside A. In another embodiment, the starting composition steviol glycoside is rebaudioside E. In another embodiment, the starting composition steviol glycoside is rebaudioside E2.
[0144] In another embodiment, the starting composition steviol glycoside is rebaudioside E4. In another embodiment, the starting composition steviol glycoside is rebaudioside E6. In another embodiment, the starting composition steviol glycoside is rebaudioside E3. In another embodiment, the starting composition steviol glycoside is rebaudioside D. In another embodiment, the starting composition steviol glycoside is rebaudioside I. In another embodiment, the starting composition steviol glycoside is rebaudioside AM.
[0145] In another embodiment, the starting composition steviol glycoside is rebaudioside D7. In another embodiment, the starting composition steviol glycoside is rebaudioside M. In another embodiment, the starting composition steviol glycoside is rebaudioside M4.
[0146] The term "polyol" refers to a molecule that contains more than one hydroxyl group. Polyols may be diols, triols, or tetraols, containing two, three, and four hydroxyl groups, respectively. Polyols may also contain more than four hydroxyl groups, such as pentaols, hexaols, and heptaols, containing five, six, or seven hydroxyl groups, respectively. Furthermore, polyols may also be sugar alcohols, polyhydric alcohols, or polyalcohols that are reduced forms of carbohydrates, where the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Examples of polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolysates, polyglycitols and sugar alcohols, or any other carbohydrates capable of being reduced.
[0147] The term "carbohydrate" refers to multiply hydroxyl-substituted aldehyde or ketone compounds of the general formula (CHO)n, where n is 3-30, as well as oligomers and polymers thereof. The carbohydrates of the present invention may further be substituted or deoxygenated at one or more positions. Carbohydrates, as used herein, include unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates. As used herein, the phrases "carbohydrate derivatives", "substituted carbohydrates", and "modified carbohydrates" are synonymous. Modified carbohydrates refer to any carbohydrate in which at least one atom has been added, removed, or replaced, or a combination thereof. Thus, carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The carbohydrate derivative or substituted carbohydrate may optionally be deoxygenated at any corresponding C position and / or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivative, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oxyimino, hydrazino, carbamyl, phospho, phosphonato, or any other viable functional group, provided that the carbohydrate derivative or substituted carbohydrate serves the function of improving the sweetness of the sweetener composition.
[0148] Examples of carbohydrates that may be used according to the invention include tagatose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, amylopectin, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono-lactone, abequose, galactosamine, sugar beet oligosaccharides, isomaltulose, erythrose, malt ... Examples of oligosaccharides include, but are not limited to, tri-oligosaccharides (isomaltose, isomaltotriose, panose, etc.), xylo-oligosaccharides (xylotriose, xylobiose, etc.), xylo-terminated oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose, etc.), sorbose, nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose, etc.), maltotetraol, maltotriol, malto-oligosaccharides (maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, etc.), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, ribose, isomerized liquid sugars such as high fructose corn syrups, coupling sugars, and soybean oligosaccharides. Additionally, carbohydrates, as used herein, can be in either the D- or L-configuration.
[0149] The starting composition may be synthetic or purified (partially or wholly), commercially available, or prepared.
[0150] In one embodiment, the starting composition is glycerol.
[0151] In another embodiment, the starting composition is glucose. In another embodiment, the starting composition is rhamnose. In yet another embodiment, the starting composition is sucrose. In yet another embodiment, the starting composition is a starch. In another embodiment, the starting composition is maltodextrin. In yet another embodiment, the starting composition is cellulose. In yet another embodiment, the starting composition is amylose.
[0152] The organic compound(s) of the starting composition serve as substrate(s) for the production of the target steviol glycoside(s), as described herein.
[0153] Targeted Steviol Glycosides The target steviol glycoside of the methods of the invention can be any steviol glycoside that can be prepared by the processes disclosed herein. In one embodiment, the target steviol glycoside is steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E ... Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j ... Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s, SvG7 or other glycosides of steviol found in the Stevia rebaudiana plant, synthetic steviol glycosides, e.g., enzymatically glucosylated steviol glycosides, and combinations thereof.
[0154] In one embodiment, the target steviol glycoside is a steviol monoside. In another embodiment, the target steviol glycoside is steviolmonoside A. In another embodiment, the target steviol glycoside is steviolbioside. In another embodiment, the target steviol glycoside is steviolbioside D. In another embodiment, the target steviol glycoside is rubusoside. In another embodiment, the target steviol glycoside is steviolbioside A. In another embodiment, the target steviol glycoside is steviolbioside B. In another embodiment, the target steviol glycoside is rebaudioside B.
[0155] In another embodiment, the target steviol glycoside is stevioside.
[0156] In another embodiment, the target steviol glycoside is rebaudioside G. In another embodiment, the target steviol glycoside is stevioside A. In another embodiment, the target steviol glycoside is stevioside B. In another embodiment, the target composition steviol glycoside is stevioside C. In another embodiment, the target composition steviol glycoside is rebaudioside A. In another embodiment, the target composition steviol glycoside is rebaudioside E. In another embodiment, the target steviol glycoside is rebaudioside E2. In another embodiment, the target steviol glycoside is rebaudioside E4. In another embodiment, the target steviol glycoside is rebaudioside E6. In another embodiment, the target steviol glycoside is rebaudioside E3. In another embodiment, the target steviol glycoside is rebaudioside D. In another embodiment, the target steviol glycoside is rebaudioside I. In another embodiment, the target steviol glycoside is rebaudioside AM. In another embodiment, the target steviol glycoside is rebaudioside D7.
[0157] In another embodiment, the target steviol glycoside is rebaudioside M. In another embodiment, the target steviol glycoside is rebaudioside M4. In another embodiment, the target steviol glycoside is rebaudioside 1a. In another embodiment, the target steviol glycoside is rebaudioside 1b. In another embodiment, the target steviol glycoside is rebaudioside 1c. In another embodiment, the target steviol glycoside is rebaudioside 1d. In another embodiment, the target steviol glycoside is rebaudioside 1e. In another embodiment, the target steviol glycoside is rebaudioside 1f. In another embodiment, the target steviol glycoside is rebaudioside 1g. In another embodiment, the target steviol glycoside is rebaudioside 1h. In another embodiment, the target steviol glycoside is rebaudioside 1i. In another embodiment, the target steviol glycoside is rebaudioside 1j. In another embodiment, the target steviol glycoside is rebaudioside 1k. In another embodiment, the target steviol glycoside is rebaudioside 1l.
[0158] In another embodiment, the target steviol glycoside is rebaudioside 1m. In another embodiment, the target steviol glycoside is rebaudioside 1n. In another embodiment, the target steviol glycoside is rebaudioside 1o. In another embodiment, the target steviol glycoside is rebaudioside 1p. In another embodiment, the target steviol glycoside is rebaudioside 1q. In another embodiment, the target steviol glycoside is rebaudioside 1r. In another embodiment, the target steviol glycoside is rebaudioside 1s. In another embodiment, the target steviol glycoside is rebaudioside 1t. In another embodiment, the target steviol glycoside is rebaudioside 2a. In another embodiment, the target steviol glycoside is rebaudioside 2b. In another embodiment, the target steviol glycoside is rebaudioside 2c. In another embodiment, the target steviol glycoside is rebaudioside 2d.
[0159] In another embodiment, the target steviol glycoside is rebaudioside 2e. In another embodiment, the target steviol glycoside is rebaudioside 2f.
[0160] In another embodiment, the target steviol glycoside is rebaudioside 2g. In another embodiment, the target steviol glycoside is rebaudioside 2h. In another embodiment, the target steviol glycoside is rebaudioside 2i. In another embodiment, the target steviol glycoside is rebaudioside 2j. In another embodiment, the target steviol glycoside is rebaudioside 2k. In another embodiment, the target steviol glycoside is rebaudioside 2l. In another embodiment, the target steviol glycoside is rebaudioside 2m.
[0161] In another embodiment, the target steviol glycoside is rebaudioside 2n. In another embodiment, the target steviol glycoside is rebaudioside 2o. In another embodiment, the target steviol glycoside is rebaudioside 2p. In another embodiment, the target steviol glycoside is rebaudioside 2q. In another embodiment, the target steviol glycoside is rebaudioside 2r. In another embodiment, the target steviol glycoside is rebaudioside 2s. In another embodiment, the target steviol glycoside is SvG7.
[0162] The target steviol glycoside may exist in any polymorphic or amorphous form, including hydrates, solvates, anhydrates, or combinations thereof. In one aspect, the invention is a biocatalytic process for the production of steviolmonoside. In one aspect, the invention is a biocatalytic process for the production of steviolmonoside A. In one aspect, the invention is a biocatalytic process for the production of steviolbioside. In one aspect, the invention is a biocatalytic process for the production of steviolbioside D.
[0163] In one aspect, the invention is a biocatalytic process for the production of rubusoside. In one aspect, the invention is a biocatalytic process for the production of steviolbioside A. In one aspect, the invention is a biocatalytic process for the production of steviolbioside B. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside B. In one aspect, the invention is a biocatalytic process for the production of stevioside. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside G.
[0164] In one aspect, the invention is a biocatalytic process for the production of stevioside A. In one aspect, the invention is a biocatalytic process for the production of stevioside B. In one aspect, the present invention is a biocatalytic process for the production of Stevioside C. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside A. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside E.
[0165] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside E2. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside E4. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside E6. In one aspect, the invention is a biocatalytic process for the production of rebaudioside E3. In one aspect, the present invention is a biocatalytic process for the production of Rebaudioside D.
[0166] In one aspect, the present invention is a biocatalytic process for the production of Rebaudioside I. In one aspect, the present invention is a biocatalytic process for the production of Rebaudioside AM. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside D7. In one aspect, the invention is a biocatalytic process for the production of rebaudioside E3. In one aspect, the present invention is a biocatalytic process for the production of Rebaudioside M.
[0167] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside M4. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1a. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1b. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1c. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1d.
[0168] In one embodiment, the invention is a biocatalytic process for the production of rebaudioside 1e. In one embodiment, the invention is a biocatalytic process for the production of rebaudioside 1f. In one embodiment, the invention is a biocatalytic process for the production of rebaudioside 1g. In one embodiment, the invention is a biocatalytic process for the production of rebaudioside 1h. In one embodiment, the invention is a biocatalytic process for the production of rebaudioside 1i.
[0169] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1j. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1k. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1l. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1m. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1n.
[0170] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1o. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1p. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1q. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1r. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1s. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 1t.
[0171] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2a. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2b. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2c. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2d. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2e. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2f. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2g.
[0172] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2h. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2i. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2j. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2k. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2l.
[0173] In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2m. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2n. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2o. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2p. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2q. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2r. In one aspect, the present invention is a biocatalytic process for the production of rebaudioside 2s.
[0174] In one aspect, the invention is a biocatalytic process for the production of SvG7. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1a from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1b from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1c from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1d from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1e from a starting composition comprising rebaudioside A and UDP-glucose.
[0175] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1f from a starting composition comprising rebaudioside A and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 1 g from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1h from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1i from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1j from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1k from a starting composition comprising rebaudioside A and UDP-glucose.
[0176] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1l from a starting composition comprising rebaudioside A and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 1m from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1n from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1o from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1p from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1q from a starting composition comprising rebaudioside A and UDP-glucose.
[0177] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1r from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1s from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1t from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2a from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2b from a starting composition comprising stevioside and UDP-glucose.
[0178] In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2c from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2d from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2e from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2f from a starting composition comprising stevioside and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2g from a starting composition comprising stevioside and UDP-glucose.
[0179] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2h from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2i from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2j from a starting composition comprising stevioside and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2k from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2l from a starting composition comprising stevioside and UDP-glucose.
[0180] In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2m from a starting composition comprising stevioside and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2n from a starting composition comprising stevioside and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2o from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2p from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2q from a starting composition comprising stevioside and UDP-glucose.
[0181] In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 2r from a starting composition comprising stevioside and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2s from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside 1q from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides a biocatalytic process for the production of rebaudioside M4 from a starting composition comprising stevioside and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2a from a starting composition comprising rebaudioside AM and UDP-glucose.
[0182] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2b from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2c from a starting composition comprising rebaudioside AM and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2d from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2e from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2f from a starting composition comprising rebaudioside AM and UDP-glucose.
[0183] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2g from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2h from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2i from a starting composition comprising rebaudioside AM and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2j from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2k from a starting composition comprising rebaudioside AM and UDP-glucose.
[0184] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2l from a starting composition comprising rebaudioside AM and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2m from a starting composition comprising rebaudioside AM and UDP-glucose.
[0185] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2n from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2o from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2p from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2q from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2r from a starting composition comprising rebaudioside AM and UDP-glucose.
[0186] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2s from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1q from a starting composition comprising rebaudioside AM and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside M4 from a starting composition comprising rebaudioside AM and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2a from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2b from a starting composition comprising rebaudioside M4 and UDP-glucose.
[0187] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2c from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2d from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2e from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2f from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2g from a starting composition comprising rebaudioside M4 and UDP-glucose.
[0188] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2h from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2i from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2j from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2k from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2l from a starting composition comprising rebaudioside M4 and UDP-glucose.
[0189] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2m from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 2n from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2o from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2p from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2q from a starting composition comprising rebaudioside M4 and UDP-glucose.
[0190] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2r from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 2s from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1q from a starting composition comprising rebaudioside M4 and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1a from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1b from a starting composition comprising rebaudioside M and UDP-glucose.
[0191] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1c from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1d from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1e from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1f from a starting composition comprising rebaudioside M and UDP-glucose. In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 1 g from a starting composition comprising rebaudioside M and UDP-glucose.
[0192] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1h from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1i from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1j from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1k from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1l from a starting composition comprising rebaudioside M and UDP-glucose.
[0193] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside 1m from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1n from a starting composition comprising rebaudioside M and UDP-glucose.
[0194] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1o from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1p from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1q from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1r from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1s from a starting composition comprising rebaudioside M and UDP-glucose.
[0195] In certain aspects, the present invention provides a biocatalytic process for the production of rebaudioside 1t from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of SvG7 from a starting composition comprising stevioside and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of SvG7 from a starting composition comprising stevioside, rebaudioside A and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside AM and UDP-glucose.
[0196] In certain aspects, the present invention provides a biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside M and UDP-glucose. In certain aspects, the present invention provides a biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside M4 and UDP-glucose. Optionally, the methods of the invention further comprise separating the target steviol glycoside from the culture medium to provide a highly purified target steviol glycoside composition. The target steviol glycoside may be separated by any suitable method, such as, for example, crystallization, membrane separation, centrifugation, extraction, chromatographic separation, or a combination of such methods. In certain embodiments, the processes described herein result in a highly purified target steviol glycoside composition. The term "highly purified" as used herein refers to a composition that contains greater than about 80% by weight of the target steviol glycoside on an anhydrous (dry) basis. In one embodiment, a highly purified target steviol glycoside composition contains greater than about 90% by weight of the target steviol glycoside on an anhydrous (dry) basis, e.g., greater than about 91%, greater than about 92%, greater than about 93%, greater than about 94%, greater than about 95%, greater than about 96%, greater than about 97%, greater than about 98%, or greater than about 99% of the target steviol glycoside content on a dry basis.
[0197] In one embodiment, when the target steviol glycoside is rebaudioside M4, the process described herein provides a composition having a rebaudioside M4 content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside M4, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0198] In one embodiment, when the target steviol glycoside is rebaudioside 1a, the process described herein provides a composition having a rebaudioside 1a content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1a, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0199] In one embodiment, when the target steviol glycoside is rebaudioside 1b, the process described herein provides a composition having a rebaudioside 1b content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1b, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0200] In one embodiment, when the target steviol glycoside is rebaudioside 1c, the process described herein provides a composition having a rebaudioside 1c content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1c, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0201] In one embodiment, when the target steviol glycoside is rebaudioside 1d, the process described herein provides a composition having a rebaudioside 1d content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1d, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0202] In one embodiment, when the target steviol glycoside is rebaudioside 1e, the process described herein provides a composition having a rebaudioside 1e content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1e, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0203] In one embodiment, when the target steviol glycoside is rebaudioside 1f, the process described herein provides a composition having a rebaudioside 1f content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1f, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0204] In one embodiment, when the target steviol glycoside is 1 g rebaudioside, the process described herein provides a composition having a rebaudioside 1 g content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is 1 g rebaudioside, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0205] In one embodiment, when the target steviol glycoside is rebaudioside 1h, the process described herein provides a composition having a rebaudioside 1h content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1h, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0206] In one embodiment, when the target steviol glycoside is rebaudioside 1i, the process described herein provides a composition having a rebaudioside 1i content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1i, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0207] In one embodiment, when the target steviol glycoside is rebaudioside 1j, the process described herein provides a composition having a rebaudioside 1b content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1j, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0208] In one embodiment, when the target steviol glycoside is rebaudioside 1k, the process described herein provides a composition having a rebaudioside 1k content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1k, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0209] In one embodiment, when the target steviol glycoside is rebaudioside 1l, the process described herein provides a composition having a rebaudioside 1l content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1l, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0210] In one embodiment, when the target steviol glycoside is rebaudioside 1m, the process described herein provides a composition having a rebaudioside 1m content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1m, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0211] In one embodiment, when the target steviol glycoside is rebaudioside 1n, the process described herein provides a composition having a rebaudioside 1n content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1n, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0212] In one embodiment, when the target steviol glycoside is rebaudioside 1o, the process described herein provides a composition having a rebaudioside 1o content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1o, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0213] In one embodiment, when the target steviol glycoside is rebaudioside 1p, the process described herein provides a composition having a rebaudioside 1p content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1p, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0214] In one embodiment, when the target steviol glycoside is rebaudioside 1q, the process described herein provides a composition having a rebaudioside 1q content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1q, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0215] In one embodiment, when the target steviol glycoside is rebaudioside 1r, the process described herein provides a composition having a rebaudioside 1r content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1r, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0216] In one embodiment, when the target steviol glycoside is rebaudioside 1s, the process described herein provides a composition having a rebaudioside 1s content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1s, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0217] In one embodiment, when the target steviol glycoside is rebaudioside 1t, the process described herein provides a composition having a rebaudioside 1t content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 1t, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0218] In one embodiment, when the target steviol glycoside is rebaudioside 2a, the process described herein provides a composition having a rebaudioside 2a content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2a, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0219] In one embodiment, when the target steviol glycoside is rebaudioside 2b, the process described herein provides a composition having a rebaudioside 2b content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2b, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0220] In one embodiment, when the target steviol glycoside is rebaudioside 2c, the process described herein provides a composition having a rebaudioside 2c content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2c, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0221] In one embodiment, when the target steviol glycoside is rebaudioside 2d, the process described herein provides a composition having a rebaudioside 2d content of greater than about 90% by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2d, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0222] In one embodiment, when the target steviol glycoside is rebaudioside 2e, the process described herein provides a composition having a rebaudioside 2e content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2e, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0223] In one embodiment, when the target steviol glycoside is rebaudioside 2f, the process described herein provides a composition having a rebaudioside 2f content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2f, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0224] In one embodiment, when the target steviol glycoside is rebaudioside 2g, the process described herein provides a composition having a rebaudioside 2g content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2g, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0225] In one embodiment, when the target steviol glycoside is rebaudioside 2h, the process described herein provides a composition having a rebaudioside 2h content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2h, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0226] In one embodiment, when the target steviol glycoside is rebaudioside 2i, the process described herein provides a composition having a rebaudioside 2i content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2i, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0227] In one embodiment, when the target steviol glycoside is rebaudioside 2j, the process described herein provides a composition having a rebaudioside 2j content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2j, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0228] In one embodiment, when the target steviol glycoside is rebaudioside 2k, the process described herein provides a composition having a rebaudioside 2k content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2k, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0229] In one embodiment, when the target steviol glycoside is rebaudioside 2l, the process described herein provides a composition having a rebaudioside 2l content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2l, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0230] In one embodiment, when the target steviol glycoside is rebaudioside 2m, the process described herein provides a composition having a rebaudioside 2m content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2m, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0231] In one embodiment, when the target steviol glycoside is rebaudioside 2n, the process described herein provides a composition having a rebaudioside 2n content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2n, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0232] In one embodiment, when the target steviol glycoside is rebaudioside 2o, the process described herein provides a composition having a rebaudioside 2o content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2o, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0233] In one embodiment, when the target steviol glycoside is rebaudioside 2p, the process described herein provides a composition having a rebaudioside 2p content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2p, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0234] In one embodiment, when the target steviol glycoside is rebaudioside 2q, the process described herein provides a composition having a rebaudioside 2q content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2q, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0235] In one embodiment, when the target steviol glycoside is rebaudioside 2r, the process described herein provides a composition having a rebaudioside 2r content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2r, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0236] In one embodiment, when the target steviol glycoside is rebaudioside 2s, the process described herein provides a composition having a rebaudioside 2s content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is rebaudioside 2s, the process described herein provides a composition comprising a content of greater than about 95% by weight on a dry basis.
[0237] In one embodiment, when the target steviol glycoside is SvG7, the process described herein provides a composition having an SvG7 content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the target steviol glycoside is SvG7, the process described herein provides a composition comprising an SvG7 content of greater than about 95% by weight on a dry basis.
[0238] Microorganisms and Enzyme Preparations In one embodiment of the invention, a microorganism (microbial cell) and / or enzyme preparation is contacted with a medium containing a starting composition to produce a target steviol glycoside.
[0239] The enzymes may be provided in the form of a whole cell suspension, a crude lysate, a purified enzyme, or a combination thereof. In one embodiment, the biocatalyst is a purified enzyme capable of converting the starting composition to the target steviol glycoside. In another embodiment, the biocatalyst is a crude lysate comprising at least one enzyme capable of converting the starting composition to the target steviol glycoside. In yet another embodiment, the biocatalyst is a whole cell suspension comprising at least one enzyme capable of converting the starting composition to the target steviol glycoside.
[0240] In another embodiment, the biocatalyst is one or more microbial cells that contain an enzyme(s) capable of converting the starting composition into the target steviol glycoside. The enzymes can be located on the surface of the cell, can be located inside the cell, or can be located both on the surface and inside the cell.
[0241] Suitable enzymes for converting the starting composition to the target steviol glycoside include, but are not limited to, steviol biosynthetic enzymes, NDP-glucosyltransferase (NGT), ADP-glucosyltransferase (AGT), CDP-glucosyltransferase (CGT), GDP-glucosyltransferase (GGT), TDP-glucosyltransferase (TDP), UDP-glucosyltransferase (UGT). Optionally, suitable enzymes for converting the starting composition to the target steviol glycoside can include NDP-recycling enzyme(s), ADP-recycling enzyme(s), CDP-recycling enzyme(s), GDP-recycling enzyme(s), TDP-recycling enzyme(s), and / or UDP-recycling enzyme(s).
[0242] In one embodiment, steviol biosynthetic enzymes include mevalonate (MVA) pathway enzymes.
[0243] In another embodiment, steviol biosynthetic enzymes include non-mevalonate 2-C-methyl-D-erythritol-4-phosphate pathway (MEP / DOXP) enzymes.
[0244] In one embodiment, the steviol biosynthetic enzymes are geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase ( CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (HDR), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase, and the like.
[0245] The UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol and / or steviol glycoside substrates to provide the target steviol glycoside.
[0246] In one embodiment, the steviol biosynthetic enzymes and UDP-glucosyltransferase are produced in a microbial cell. The microbial cell can be, for example, E. coli, Saccharomyces spp., Aspergillus spp., Pichia spp., Bacillus spp., Yarrowia spp., etc. In another embodiment, the UDP-glucosyltransferase is synthetic.
[0247] In one embodiment, the UDP-glucosyltransferase is selected from the group including UGT74G1, UGT85C2, UGT76G1, UGT91D2, UGTSI2, EUGT11, and UGTs having substantial (greater than 85%, greater than 86%, greater than 87%, greater than 88%, greater than 89%, greater than 90%, greater than 91%, greater than 92%, greater than 93%, greater than 94%, greater than 95%, greater than 96%, greater than 97%, greater than 98%, greater than 99%) amino acid sequence identity to these polypeptides, and isolated nucleic acid molecules encoding these UGTs.
[0248] In one embodiment, the steviol biosynthetic enzymes, UGTs, and UDP-glucose recycling system are present in one microorganism (microbial cell). The microorganism can be, for example, Escherichia coli, Saccharomyces spp., Aspergillus spp., Pichia spp., Bacillus spp., Yarrowia spp., etc.
[0249] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol, or any starting steviol glycoside bearing an -OH functional group at C 13, to give a target steviol glycoside having an -O-glucose beta glucopyranoside glycosidic linkage at C 13. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0250] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol, or any starting steviol glycoside bearing a -COOH functional group at C19, to give a target steviol glycoside having a -COO-glucose beta-glucopyranoside glycosidic bond at C19. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0251] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→2 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0252] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→3 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0253] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→4 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In another specific embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0254] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→6 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0255] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→2 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0256] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→3 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0257] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→4 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In another specific embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0258] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side chain of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1→6 glucopyranoside glycosidic bond(s) in the newly generated glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0259] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to produce a steviol monoside, hi a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0260] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to produce steviolmonoside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0261] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to produce steviolbioside. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0262] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to produce steviolbioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1. In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to produce rubusoside. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0263] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to produce rubusoside. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0264] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to produce steviolbioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0265] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to produce steviolbioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0266] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol monoside bioside to produce rebaudioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0267] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside to produce stevioside. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0268] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to produce rebaudioside B. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0269] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to produce rebaudioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0270] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce stevioside. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2.
[0271] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce rebaudioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0272] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce stevioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0273] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to produce stevioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0274] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to produce stevioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0275] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to produce stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0276] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to produce stevioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0277] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to produce stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0278] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside B to produce rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having greater than 85% amino acid sequence identity to UGT74G1.
[0279] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to produce rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0280] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to produce rebaudioside E. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0281] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to produce rebaudioside E2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0282] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to produce rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0283] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to produce rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0284] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to produce rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0285] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to produce rebaudioside E. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0286] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to produce rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0287] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to produce rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0288] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to produce rebaudioside E2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0289] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to produce rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0290] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to produce rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0291] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to produce rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having greater than 85% amino acid sequence identity to UGT85C2.
[0292] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to produce rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0293] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to produce rebaudioside I. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0294] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to produce rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0295] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to produce rebaudioside AM. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0296] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to produce rebaudioside I. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0297] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to produce rebaudioside AM. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0298] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to produce rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0299] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to produce rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0300] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to produce rebaudioside I. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0301] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to produce rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0302] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to produce rebaudioside AM. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0303] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to produce rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0304] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0305] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside I to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0306] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0307] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to produce rebaudioside M4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0308] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D7 to produce rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0309] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1a. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0310] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1b. In a particular embodiment, the UDP-7 glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0311] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1c. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0312] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1d. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0313] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1e. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0314] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1f. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0315] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1g. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0316] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1h. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0317] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1i. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0318] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1j. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0319] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1k. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0320] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1l. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0321] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1m. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0322] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1n. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0323] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1o. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0324] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1p. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0325] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1q. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0326] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1r. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0327] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1s. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0328] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to produce rebaudioside 1t. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0329] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2a. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0330] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2b. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0331] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2c. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0332] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2d. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0333] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2e. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0334] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2f. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0335] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2g. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0336] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2h. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0337] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2i. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0338] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2j. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0339] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2k. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0340] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2l. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0341] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2m. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0342] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2n. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2.
[0343] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2o. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0344] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2p. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0345] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2q. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity with UGT76G1.
[0346] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2r. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity with UGT76G1.
[0347] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 2s. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity to UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity to UGT76G1.
[0348] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to produce rebaudioside 1q. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having greater than 85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having greater than 85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having greater than 85% amino acid sequence identity with UGT91D2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having greater than 85% amino acid sequence identity with UGT76G1.
[0349] Optionally, the method further comprises recycling UDP to provide UDP-glucose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate such that biotranslation of steviol and / or steviol glycoside substrates to target steviol glycosides is carried out using catalytic amounts of UDP-glucosyltransferase and UDP-glucose.
[0350] In one embodiment, the recycling catalyst is sucrose synthase SuSy_At or a sucrose synthase having greater than 85% amino acid sequence identity to SuSy_At.
[0351] In one embodiment, the recycling substrate for the UDP-glucose recycling catalyst is sucrose.
[0352] Optionally, the method of the present invention further comprises the use of a transglycosidase to modify the recipient target steviol glycoside molecule using an oligosaccharide or polysaccharide as a sugar donor. Non-limiting examples include cyclodextrin glycosyltransferase (CGTase), fructofuranosidase, amylase, saccharase, glucosucrase, beta-h-fructosidase, beta-fructosidase, sucrase, fructosyl invertase, alkaline invertase, acid invertase, and fructofuranosidase. In some embodiments, sugar(s) other than glucose, including but not limited to, fructose, xylose, rhamnose, arabinose, deoxyglucose, and galactose, are translocated to the recipient target steviol glycoside. In one embodiment, the recipient steviol glycoside is rebaudioside 1a, rebaudioside 1b, rebaudioside 1c, rebaudioside 1d, rebaudioside 1e, rebaudioside 1f, rebaudioside 1g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r ... In another embodiment, the recipient steviol glycoside is rebaudioside M4, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, and / or rebaudioside 2s. In another embodiment, the recipient steviol glycoside is rebaudioside M4. In another embodiment, the recipient steviol glycoside is SvG7.
[0353] In another embodiment, the UDP-glucosyltransferase capable of adding at least one glucose unit to the starting composition steviol glycoside has greater than 85% amino acid sequence identity to a UGT selected from the following list of GenInfo Identification Numbers, preferably from the group shown in Tables 1 and 2:
[0354] [Table 1-1]
[0355] [Table 1-2]
[0356] [Table 1-3]
[0357] [Table 2-1]
[0358] [Table 2-2]
[0359] [Table 2-3]
[0360] [Table 3]
[0361] One aspect of the invention is a microbial cell that contains an enzyme, i.e., an enzyme capable of converting a starting composition into a target steviol glycoside. Thus, some aspects of the invention include contacting a microorganism with a medium containing a starting composition to provide a medium that contains at least one target steviol glycoside.
[0362] The microorganism can be any microorganism that possesses the enzyme(s) necessary to convert the starting composition into the target steviol glycoside(s). These enzymes are encoded within the genome of the microorganism.
[0363] Suitable microorganisms include, but are not limited to, Escherichia coli, Saccharomyces spp., Aspergillus spp., Pichia spp., Bacillus spp., Yarrowia spp., and the like.
[0364] In one embodiment, the microorganisms are free when contacted with the starting composition.
[0365] In another embodiment, the microorganism is immobilized when contacted with the starting composition. For example, the microorganism can be immobilized on a solid support made of inorganic or organic materials. Non-limiting examples of solid supports suitable for immobilizing microorganisms include derivatized cellulose or glass, ceramics, metal oxides or membranes. The microorganism can be immobilized on the solid support by, for example, covalent binding, adsorption, cross-linking, entrapment or encapsulation.
[0366] In yet another embodiment, the enzymes capable of converting the starting composition to the target steviol glycosides are secreted from the microorganism into the reaction medium.
[0367] The target steviol glycoside is optionally purified. Purification of the target steviol glycoside from the reaction medium can be accomplished by at least one suitable method to provide a highly purified target steviol glycoside composition. Suitable methods include crystallization, membrane separation, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods.
[0368] use Highly purified target glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside G, rebaudioside H, rebaudioside I, rebaudioside N, rebaudioside N, rebaudioside N, rebaudioside N, rebaudioside B, rebaudioside B, rebaudioside C, rebaudioside B, rebaudioside N ... Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2 Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s, and / or SvG7 can be used "as is" or in combination with other sweeteners, flavorings, food ingredients, and combinations thereof.
[0369] Non-limiting examples of flavorings include, but are not limited to, lime, lemon, orange, fruit, banana, grape, pear, pineapple, mango, berry, bitter almond, cola, cinnamon, sugar, cotton candy, vanilla, and combinations thereof.
[0370] Non-limiting examples of other food ingredients include, but are not limited to, acidulants, organic acids and amino acids, colorants, bulking agents, modified starches, gums, texturizers, preservatives, caffeine, antioxidants, emulsifiers, stabilizers, thickeners, gelling agents, and combinations thereof.
[0371] Highly purified target glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside G, rebaudioside H, rebaudioside I, rebaudioside N, rebaudioside N, rebaudioside N, rebaudioside N, rebaudioside N, rebaudioside B, rebaudioside B, rebaudioside C, rebaudioside B, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside G, rebaudioside H, rebaudioside N ... Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i , Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2c ... Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s, and / or SvG7 may be prepared in various polymorphic forms, including, but not limited to, hydrates, solvates, anhydrates, amorphous forms, and combinations thereof.
[0372] Highly purified target glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, obtained according to the present invention. , Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2 Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be incorporated as high intensity natural sweeteners in foods, beverages, pharmaceutical compositions, cosmetics, chewing gum, tabletop products, cereals, dairy products, toothpastes, and other oral compositions, and the like.
[0373] In some embodiments, the highly purified target glycoside(s) of the present invention are present in foods, beverages, pharmaceutical compositions, cosmetics, chewing gums, tabletop products, cereals, dairy products, toothpastes, and other oral compositions, and the like, at about 0.0001% to about 12% by weight, e.g., about 0.0001%, about 0.0005%, about 0.001%, about 0.005%, about 0.01%, about 0.05%, about 0.1%, about 0.5%, about 1. 0% by weight, about 1.5% by weight, about 2.0% by weight, about 2.5% by weight, about 3.0% by weight, about 3.5% by weight, 4.0% by weight, about 4.5% by weight, about 5.0% by weight, about 5.5% by weight, about 6.0% by weight, about 6.5% by weight, about 7.0% by weight, about 7.5% by weight, about 8.0% by weight, about 8.5% by weight, about 9.0% by weight, about 9.5% by weight, about 10.0% by weight, about 10.5% by weight, about 11.0% by weight, about 11.5% by weight or about 12.0% by weight, etc.
[0374] In certain embodiments, the sweetener is present in the beverage in an amount of about 0.0001% to about 8% by weight, e.g., about 0.0001% to about 0.0005% by weight, about 0.0005% to about 0.001% by weight, about 0.001% to about 0.005% by weight, about 0.005% to about 0.01% by weight, about 0.01% to about 0.05% by weight, about 0.05% to about 0.1% by weight, about 0.1% to about 0.5% by weight, about 0.5% to about 1% by weight, about 1% to about 2% by weight, about 2% to about 3% by weight, about 3% to about 4% by weight, about 4% to about 5% by weight, about 5% to about 6% by weight, about 6% to about 7% by weight, and about 7% to about 8% by weight, etc.
[0375] Highly purified target glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside B, rebaudioside C, rebaudioside D ... Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s, SvG7 and / or combinations thereof may be used as the sweetening compound or it may be Dulcoside A, Dulcoside B, Dulcoside C, Dulcoside D, Rebaudioside A 2, Rebaudioside A3, Rebaudioside A4, Rebaudioside B2, Rebaudioside C, Rebaudioside C2, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside D2, Rebaudioside D3, Rebaudioside D4, Rebaudioside D5, Rebaudioside D6, Rebaudioside D8, Rebaudioside E5, Rebaudioside E7, Rebaudioside F, Rebaudioside F2, Rebaudioside F3, Rebaudioside H, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5,Rebaudioside H6, Rebaudioside I2, Rebaudioside I3, Rebaudioside J, Rebaudioside K, Rebaudioside K2, Rebaudioside KA, Rebaudioside L, Rebaudioside M2, Rebaudioside M3, Rebaudioside N, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside O, Rebaudioside O2, Rebaudioside O3, Rebaudioside O4, Rebaudioside Q, Rebaudioside Q2, Rebaudioside Q 3, Rebaudioside R, Rebaudioside S, Rebaudioside T, Rebaudioside T1, Rebaudioside U, Rebaudioside U2, Rebaudioside V, Rebaudioside V2, Rebaudioside V3, Rebaudioside W, Rebaudioside W2, Rebaudioside W3, Rebaudioside Y, Rebaudioside Z1, Rebaudioside Z2, Steviolbioside C, Steviolbioside E, Stevioside D, Stevioside E, Stevioside E2, Stevioside F, Stevioside G, Steviolbioside C, Steviolbioside D, Stevioside E, Stevioside E2, Stevioside F, Stevioside G, Steviolbioside C, Steviolbioside D, Steviolbioside E, Steviolbioside E2, Steviolbioside F, Steviolbioside G, Steviolbioside C ... Bioside H, mogrosides, brazzein, neohesperidin dihydrochalcone, glycyrrhizic acid and its salts, thaumatin, perillartine, pernandulcin, mukuroziosides, baiyunoside, phlomisoside I, dimethyl-hexahydrofluorene-dicarboxylic acid, abrusosides, periandrin, carnosiflosides, cyclocaryoside, pterocaryosides, polypodoside A, brazilin, hernandulcin, phyllodulcin, The sweetener may be used in combination with at least one naturally occurring high intensity sweetener, such as glycyphyllin, phlorizin, trilobatin, dihydroflavonol, dihydroquercetin-3-acetate, neoastilibin, trans-cinnamaldehyde, monatin, monatin salts, other indole derivative sweeteners, seligeain A, hematoxylin, monellin, osladin, pterocaryoside A, pterocaryoside B, mabinlin, pentajin, miraculin, curculin, neoculin, chlorogenic acid, cynarin, LuoHan Guo sweetener, mogroside V, siamenoside, sciratose, and combinations thereof.
[0376] In certain embodiments, steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M 4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 are selected from the group consisting of Dulcoside A, Dulcoside B, Dulcoside C, Dulcoside D, Rebaudioside A2, Rebaudioside A3, Rebaudioside A4, Rebaudioside B2, Rebaudioside C, Rebaudioside C2, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside D2, Rebaudioside D3, Rebaudioside D4, Rebaudioside D5, Rebaudioside D6, Rebaudioside D8, Rebaudioside E5, Rebaudioside E7, Rebaudioside F, Rebaudioside F2, Rebaudioside F3, Rebaudioside H, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside I2, Rebaudioside I3, Rebaudioside J, Rebaudioside K, Rebaudioside K2,Rebaudioside KA, Rebaudioside L, Rebaudioside M2, Rebaudioside M3, Rebaudioside N, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside O, Rebaudioside O2, Rebaudioside O3, Rebaudioside O4, Rebaudioside Q, Rebaudioside Q2, Rebaudioside Q3, Rebaudioside R, Rebaudioside S, Rebaudioside T, Rebaudioside T1, Rebaudioside The sweetener composition may include a compound selected from the group consisting of steviolbioside U, rebaudioside U2, rebaudioside V, rebaudioside V2, rebaudioside V3, rebaudioside W, rebaudioside W2, rebaudioside W3, rebaudioside Y, rebaudioside Z1, rebaudioside Z2, steviolbioside C, steviolbioside E, stevioside D, stevioside E, stevioside E2, stevioside F, stevioside G, stevioside H, NSF-02, mogroside V, sciratose, Luo Han Guo, allulose, allose, D-tagatose, erythritol, and combinations thereof.
[0377] Highly purified target glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E1, rebaudioside E2, rebaudioside E3, rebaudioside E4, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside E8, rebaudioside E9, rebaudioside E10, rebaudioside E11, rebaudioside E12, rebaudioside E13, rebaudioside E14, rebaudioside E15, rebaudioside E16, rebaudioside E17, rebaudioside E18, rebaudioside E19, rebaudioside E20, rebaudioside E21, rebaudioside E22, rebaudioside E23, rebaudioside E24, rebaudioside E25, rebaudioside E26, rebaudioside E27, rebaudioside E28, rebaudioside E29, rebaudioside E31, rebaudioside E32, rebaudioside E33, rebaudioside E34, rebaudioside E35, rebaudioside E36, rebaudioside E37, rebaudioside E38, rebaudioside E39, rebaudioside E40, re Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m ... Udioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may also be used in combination with synthetic high intensity sweeteners such as sucralose, acesulfame potassium, aspartame, alitame, saccharin, neohesperidine dihydrochalcone, cyclamate, neotame, dulcin, suosan, advantame, salts thereof, and combinations thereof.
[0378] Further, the present invention provides a method for producing highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside G, rebaudioside H, rebaudioside I, rebaudioside N ... Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be used in combination with gymnemic acid, phozurcin, digiphin, lactisol or other natural sweetener reducers.Steviolmonoside, Steviolmonoside A, Steviolbioside, Steviolbioside D, Rubusoside, Steviolbioside A, Steviolbioside B, Rebaudioside B, Stevioside, Rebaudioside G, Stevioside A, Stevioside B, Stevioside C, Rebaudioside A, Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i , rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2m, rebaudioside 2m, rebaudioside 2n, rebaudioside 2m, rebaudioside 2n Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s, and / or SvG7 may also be combined with various umami enhancers.Steviolmonoside, Steviolmonoside A, Steviolbioside, Steviolbioside D, Rubusoside, Steviolbioside A, Steviolbioside B, Rebaudioside B, Stevioside, Rebaudioside G, Stevioside A, Stevioside B, Stevioside C, Rebaudioside A, Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k , Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be mixed with umami and sweet amino acids such as glutamate, aspartic acid, glycine, alanine, threonine, proline, serine, glutamate, lysine, tryptophan and combinations thereof.
[0379] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside E4, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside E8, rebaudioside E9, rebaudioside E10, rebaudioside E11, rebaudioside E12, rebaudioside E13, rebaudioside E14, rebaudioside E15, rebaudioside E16, rebaudioside E17, rebaudioside E18, rebaudioside E19, rebaudioside E20, rebaudioside E21, rebaudioside E22, rebaudioside E23, rebaudioside E24, rebaudioside E25, rebaudioside E26, rebaudioside E27, rebaudioside E28, rebaudioside E29, rebaudioside E30, rebaudioside E31, rebaudioside E32, rebaudioside E33, rebaudioside E34, rebaudioside E35, rebaudioside E36, rebaudioside E37, rebaudioside E38, rebaudioside E39, rebaudioside E40, rebaudioside E41, rebaudioside E42, rebaudioside E4 Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and and / or SvG7 may be used in combination with one or more additives selected from the group consisting of carbohydrates, polyols, amino acids and their corresponding salts, polyamino acids and their corresponding salts, sugar acids and their corresponding salts, nucleotides, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, flavoring agents and flavoring ingredients, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers, and combinations thereof.
[0380] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E , Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e , rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and / or SvG7 may be combined with a polyol or sugar alcohol. The term "polyol" refers to a molecule that contains more than one hydroxyl group. Polyols may be diols, triols, or tetraols, which contain two, three, and four hydroxyl groups, respectively. Polyols may also contain more than four hydroxyl groups, such as pentaols, hexaols, and heptaols, which contain five, six, or seven hydroxyl groups, respectively. Additionally, the polyol may also be a sugar alcohol, a polyhydric alcohol, or a polyalcohol that is a reduced form of a carbohydrate (wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group).Examples of polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolysates, polyglycitols and sugar alcohols, or any other carbohydrates capable of being reduced without adversely affecting the taste of the sweetener composition.
[0381] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2 , Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2 h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and / or SvG7 may be combined with a low calorie sweetener such as, for example, D-tagatose, L-sugars, L-sorbose, L-arabinose, and combinations thereof.
[0382] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudio SvG7, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and / or SvG7 may also be combined with various carbohydrates. The term "carbohydrate" generally refers to multi-hydroxyl substituted aldehyde or ketone compounds of the general formula (CHO), where n is 3-30, as well as oligomers and polymers thereof. The carbohydrates of the present invention may further be substituted or deoxygenated at one or more positions. Carbohydrates, as used herein, include unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates. As used herein, the phrases "carbohydrate derivative," "substituted carbohydrate," and "modified carbohydrate" are synonymous. Modified carbohydrate refers to any carbohydrate in which at least one atom has been added, removed, or replaced, or a combination thereof.Thus, the carbohydrate derivatives or substituted carbohydrates encompass substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The carbohydrate derivatives or substituted carbohydrates may optionally be deoxygenated at any corresponding C-position and / or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oxyimino, hydrazino, carbamyl, phospho, phosphonato, or any other viable functional group, provided that the carbohydrate derivatives or substituted carbohydrates serve the function of improving the sweetness of the sweetener composition.
[0383] Examples of carbohydrates that may be used according to the invention include psicose, turanose, allose, tagatose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, amylopectin, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono-lactone, abequose, galactosamine, and sugar beet oligosaccharides. , isomalto-oligosaccharides (isomaltose, isomaltotriose, panose, etc.), xylo-oligosaccharides (xylotriose, xylobiose, etc.), xylo-terminal oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose, etc.), sorbose, nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose, etc.), maltotetraose, Examples of carbohydrates include, but are not limited to, maltool, maltotriol, malto-oligosaccharides (such as maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, etc.), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, ribose, isomerized liquid sugars such as high fructose corn syrups, coupling sugars, and soybean oligosaccharides. Furthermore, carbohydrates as used herein may exist in either the D- or L-configuration.
[0384] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside D, rubusoside ... Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be used in combination with various physiologically active substances or functional ingredients. The functional ingredients are generally classified into categories such as carotenoids, dietary fiber, fatty acids, saponins, antioxidants, nutraceuticals, flavonoids, isothiocyanates, phenols, plant sterols and stanols (phytosterols and phytostanols); polyols; prebiotics, probiotics; phytoestrogens; soy proteins; sulfides / thiols; amino acids; proteins; vitamins; and minerals. Functional ingredients can also be categorized based on their health benefits, such as cardiovascular, cholesterol-lowering, and anti-inflammatory.Exemplary functional ingredients are provided in WO 2013 / 096420, the contents of which are incorporated herein by reference.
[0385] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E obtained according to the present invention. , Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside Udioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be applied as high intensity sweeteners to produce zero calorie, low calorie or diabetic beverages and foods with improved taste characteristics. It may also be used in beverages, foodstuffs, medicines and other products where sugar cannot be used.Additionally, highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E 2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 can be used as sweeteners for drinks, food, and other products for human consumption, as well as in animal feeds and feeds where the properties are improved.
[0386] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside G, stevioside B, stevioside C, rebaudioside A, rebaudioside G, stevioside B, stevioside C, rebaudioside D, steviolmonoside A, steviolbioside D, steviolmonoside A, steviolbioside D, steviolmonoside B, steviolmonoside A, steviolbioside D, steviolmonoside B, steviolmonoside B, steviolmonoside C, steviolmonoside B, steviolmono ... B, steviolmonoside C, steviolmonoside B, steviolmonoside B, steviolmonoside B, steviolmonoside C, st Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside Udioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be applied as foam suppressants to produce zero calorie, low calorie or diabetic beverages and foods.
[0387] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside
[0033] Examples of consumer products in which SvG7, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be used as sweetening compounds include alcoholic beverages such as vodka, wine, beer, spirits, and sake; natural juices; soft drinks; carbonated soft drinks. ;Diet drinks;Zero calorie drinks;Low calorie drinks and foods;Yogurt drinks;Instant juice;Instant coffee;Instant drinks in powder form;Canned products;Syrup;Fermented soybean paste;Soy sauce;Vinegar;Dressing;Mayonnaise;Ketchup;Curry;Soup;Dashi stock;Soy sauce powder;Vinegar powder;Biscuits;Rice crackers;Crackers;Bread;Chocolate;Caramel;Candy;Chewing gum;Jelly;Pudding;Preserved fruits and vegetables;Fresh cream;Jam;Marmalade;Flower paste;Milk powder;Ice cream;Sorbet;These include, but are not limited to, bottled vegetables and fruits; canned boiled beans; meat and food products boiled in sweet sauce; agricultural products; seafood; ham; sausage; fish ham; fish sausage; fish paste; fried fish products; dried seafood; frozen foods, preserved seaweed; preserved meat; tobacco and medicines, etc. In principle, it may be without restrictions in application;
[0388] Highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D 7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c
[0033] Examples of consumer products in which Rebaudioside 2d, Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 may be used as flavor modifiers or flavors having modifying properties include alcoholic beverages such as vodka, wine, beer, spirits, and sake; natural juices ;Soft drinks;Carbonated soft drinks;Diet drinks;Zero calorie drinks;Low calorie drinks and foods;Yogurt drinks;Instant juice;Instant coffee;Instant drinks in powder form;Canned products;Syrup;Fermented soybean paste;Soy sauce;Vinegar;Dressing;Mayonnaise;Ketchup;Curry;Soup;Dashi stock;Soy sauce powder;Vinegar powder;Biscuits;Rice crackers;Crackers;Bread;Chocolate;Caramel;Candy;Chewing gum;Jelly;Pudding;Preserved fruits and vegetables;Fresh cream;Jam;Marmalade;Flower paste;Milk powder;These include, but are not limited to, ice cream; sorbet; bottled vegetables and fruits; canned boiled beans; meat and food products boiled in sweet sauce; agricultural products; seafood; ham; sausage; fish ham; fish sausage; fish paste; fried fish products; dried seafood; frozen foods, preserved seaweed; preserved meat; tobacco and medicines, etc. In principle, it may be without restrictions in application;
[0389] During the manufacture of products such as food, beverages, pharmaceuticals, cosmetics, tabletop products, and chewing gum, conventional methods such as mixing, kneading, dissolving, pickling, permeating, infusing, sprinkling, spraying, pouring, and other methods may be used.
[0390] Furthermore, the highly purified target steviol glycoside(s) obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A , Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1 g, rebaudioside 1h, rebaudioside 1i, rebaudioside 1j, rebaudioside 1k, rebaudioside 1l, rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d ...c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside 2c, rebaudioside Rebaudioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s, and / or SvG7 may be used in dry or liquid form.
[0391] The highly purified target steviol glycoside may be added before or after the heat treatment of the food product. The highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside G, rebaudioside H, rebaudioside I, rebaudioside N ... Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1c ... Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d ... The amount of Udioside 2e, Rebaudioside 2f, Rebaudioside 2g, Rebaudioside 2h, Rebaudioside 2i, Rebaudioside 2j, Rebaudioside 2k, Rebaudioside 2l, Rebaudioside 2m, Rebaudioside 2n, Rebaudioside 2o, Rebaudioside 2p, Rebaudioside 2q, Rebaudioside 2r, Rebaudioside 2s and / or SvG7 will depend on the purpose of use. As noted above, it may be added alone or in combination with other compounds.
[0392] The present invention also provides steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside B5, rebaudioside C6, rebaudioside D7, rebaudioside E8, rebaudioside E9, rebaudioside E10, rebaudioside E11, rebaudioside E12, rebaudioside E13, rebaudioside E14, rebaudioside E15, rebaudioside E16, rebaudioside E17, rebaudioside E18, rebaudioside E19, rebaudioside E20, rebaudioside E21, rebaudioside E22, rebaudioside E23, rebaudioside E24, rebaudioside E25, rebaudioside E26, rebaudioside E27, rebaudioside E28, rebaudioside E29, rebaudioside E30, rebaudioside E31, rebaudioside E32, rebaudioside E33, rebaudioside E34, rebaudioside E35, rebaudioside E36, rebaudioside E37, rebaudioside E38, rebaudioside E39, rebaudioside E38 Udioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e ... 2. The sweetness enhancer of claim 1, wherein steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rubusoside, steviolbioside C, rubusoside D, rubusoside E, rubusoside F, rubusoside G, rubusoside H, rubusoside I ... Rebaudioside B, Rebaudioside B, Stevioside, Rebaudioside G, Stevioside A, Stevioside B, Stevioside C, Rebaudioside A, Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h,Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2c, Rebaudioside 2d, Rebaudioside 2e ... Udioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and / or SvG7 are present at a concentration at or below their respective sweetness perception thresholds.
[0393] As used herein, the term "sweetness enhancer" refers to a compound capable of enhancing or intensifying the perception of sweetness in a composition, such as a beverage. The term "sweetness enhancer" is synonymous with the terms "sweetness potentiator," "sweetness enhancer," "sweetness amplifier," and "sweetness enhancer."
[0394] The term "sweetness perception threshold concentration" as generally used herein refers to the lowest known concentration of a sweet compound that can be perceived by the human palate, usually around 1.0% sucrose equivalent (1.0% SE). In general, sweetness enhancers can enhance or increase the sweetness of a sweetener without providing any noticeable sweetness by themselves when present at or below the sweetness perception threshold concentration of a given sweetness enhancer, but sweetness enhancers themselves can provide sweetness at concentrations above their sweetness perception threshold concentration. Sweetness perception threshold concentrations are specific to a particular enhancer and can vary based on the beverage matrix. Sweetness perception threshold concentrations can be easily determined by taste testing increasing concentrations of a given enhancer until a sucrose equivalent greater than 1.0% in a given beverage matrix is detected. The concentration that provides approximately 1.0% sucrose equivalent is considered to be the sweetness perception threshold.
[0395] In some embodiments, the sweetener is present in the beverage at a concentration of about 0.0001% to about 12% by weight, e.g., about 0.0001%, about 0.0005%, about 0.001%, about 0.005%, about 0.01%, about 0.05%, about 0.1%, about 0.5%, about 1.0%, about 1.5%, about 2.0%, about 2.5%, about 3.0%, about 4.0%, about 5.0%, about 6.0%, about 7.0%, about 8.0%, about 9.0%, about 10.0%, about 11.0%, about 12.0%, about 13.0%, about 14.0%, about 15.0%, about 16.0%, about 17.0%, about 18.0%, about 19.0%, about 20.0%, about 21.0%, about 22.0%, about 23.0%, about 24.0%, about 25.0%, about 26.0%, about 27.0%, about 28.0%, about 29.0%, about 30.0%, about 31.0%, about 32.0%, about 33.0%, about 34.0%, about 35.0%, about 36.0%, about 37.0%, about 38.0%, about 39.0%, about 40.0%, about 41.0%, about 42.0%, about 43.0%, about 44.0%, about 45.0%, about 46.0%, about 47.0%, about 48.0%, about 49.0%, about 50.0%, about 51.0%, about 52.0%, about 53.0%, about 54.0%, about 55.0%, about 56.0%, about 57.0%, about 58.0%, about 5 %, about 3.5%, 4.0%, about 4.5%, about 5.0%, about 5.5%, about 6.0%, about 6.5%, about 7.0%, about 7.5%, about 8.0%, about 8.5%, about 9.0%, about 9.5%, about 10.0%, about 10.5%, about 11.0%, about 11.5% or 12.0% by weight, etc.
[0396] In certain embodiments, the sweetener is present in the beverage in an amount of from about 0.0001% to about 10% by weight, e.g., from about 0.0001% to about 0.0005% by weight, from about 0.0005% to about 0.001% by weight, from about 0.001% to about 0.005% by weight, from about 0.005% to about 0.01% by weight, from about 0.01% to about 0.05% by weight, from about 0.05% to about 0. The sweetener is present in an amount of about 1% by weight, about 0.1% to about 0.5% by weight, about 0.5% to about 1% by weight, about 1% to about 2% by weight, about 2% to about 3% by weight, about 3% to about 4% by weight, about 4% to about 5% by weight, about 5% to about 6% by weight, about 6% to about 7% by weight, about 7% to about 8% by weight, about 8% to about 9% by weight, or about 9% to about 10% by weight, etc. In a particular embodiment, the sweetener is present in the beverage in an amount of about 0.5% to about 10% by weight. In another particular embodiment, the sweetener is present in the beverage in an amount of about 2% to about 8% by weight.
[0397] In one embodiment, the sweetener is a traditional calorie sweetener.Suitable sweeteners include, but are not limited to, sucrose, fructose, glucose, high fructose corn syrup and high fructose starch syrup.In another embodiment, the sweetener is erythritol.In yet another embodiment, the sweetener is a rare sugar.Suitable rare sugars include, but are not limited to, D-allose, D-psicose, D-ribose, D-tagatose, L-glucose, L-fucose, L-arabinose, D-turanose, D-leucrose and combinations thereof.
[0398] It is contemplated that the sweetener may be used alone or in combination with other sweeteners.
[0399] In one embodiment, the rare sugar is D-allose. In a more particular embodiment, the D-allose is present in the beverage in an amount of about 0.5% by weight to about 10% by weight, such as about 2% to about 8%.
[0400] In another embodiment, the rare sugar is D-psicose. In a more particular embodiment, D-psicose is present in the beverage in an amount of about 0.5% by weight to about 10% by weight, such as about 2% to about 8%.
[0401] In yet another embodiment, the rare sugar is D-ribose. In a more particular embodiment, the D-ribose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as about 2% to about 8%.
[0402] In yet another embodiment, the rare sugar is D-tagatose. In a more particular embodiment, D-tagatose is present in the beverage in an amount of about 0.5% by weight to about 10% by weight, such as about 2% to about 8%.
[0403] In a further embodiment, the rare sugar is L-glucose. In a more particular embodiment, the L-glucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8%.
[0404] In one embodiment, the rare sugar is L-fucose. In a more particular embodiment, L-fucose is present in the beverage in an amount of about 0.5% by weight to about 10% by weight, such as about 2% to about 8%.
[0405] In another embodiment, the rare sugar is L-arabinose. In a more particular embodiment, the L-arabinose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as about 2% to about 8%.
[0406] In yet another embodiment, the rare sugar is D-turanose. In a more particular embodiment, the D-turanose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8%.
[0407] In yet another embodiment, the rare sugar is D-leucrose. In a more particular embodiment, the D-leucrose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8%.
[0408] The addition of a sweetness enhancer at a concentration at or below the sweetness perception threshold increases the detected sucrose equivalent of a beverage containing a sweetener and a sweetness enhancer, compared to a corresponding beverage in the absence of the sweetness enhancer. Furthermore, the sweetness can be increased by an amount greater than the detectable sweetness of a solution containing the same concentration of at least one sweetness enhancer in the absence of any sweetener.
[0409] Accordingly, the present invention also relates to a method for enhancing the sweetness of a beverage comprising a sweetener, the method comprising the steps of providing a beverage comprising a sweetener, and administering to the beverage a sweetener containing steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside E8, rebaudioside E9, rebaudioside E10, rebaudioside E11, rebaudioside E12, rebaudioside E13, rebaudioside E14, rebaudioside E15, rebaudioside E16, rebaudioside E17, rebaudioside E18, rebaudioside E19, rebaudioside E20, rebaudioside E21, rebaudioside E22, rebaudioside E23, rebaudioside E24, rebaudioside E25, rebaudioside E26, rebaudioside E27, rebaudioside E28, rebaudioside E29, rebaudioside E30, rebaudioside E31, rebaudioside E32, rebaudioside E33, rebaudioside E34, rebaudioside E35, rebaudioside E36, rebaudioside E37, rebaudioside E38, rebaudioside E39, rebaudi Udioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside and adding a sweetness enhancer selected from rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and / or SvG7, wherein the sweetness enhancer is selected from steviol monoside, steviol monositol ... Rebaudioside A, Steviolbioside, Steviolbioside D, Rubusoside, Steviolbioside A, Steviolbioside B, Rebaudioside B, Stevioside, Rebaudioside G, Stevioside A, Stevioside B, Stevioside C, Rebaudioside A, Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c,Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside 1m, Rebaudioside 1n, Rebaudioside 1o, Rebaudioside 1p, Rebaudioside 1q, Rebaudioside 1r, Rebaudioside 1s, Rebaudioside 1t, Rebaudioside 2a, Rebaudioside 2b, Rebaudioside 2 c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and / or SvG7 are present at concentrations at or below their sweetness perception thresholds.
[0410] Steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, Rebaudioside rebaudioside 1m, rebaudioside 1n, rebaudioside 1o, rebaudioside 1p, rebaudioside 1q, rebaudioside 1r, rebaudioside 1s, rebaudioside 1t, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f, rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudio The addition of rebaudioside 2l, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s, and / or SvG7 to a beverage containing a sweetener can increase the detected sucrose equivalent by about 1.0% to about 5.0%, e.g., about 1.0%, about 1.5%, about 2.0%, about 2.5%, about 3.0%, about 3.5%, about 4.0%, about 4.5% or about 5.0%.
[0411] The following examples are directed to the production of highly purified target steviol glycoside(s), in particular steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside D, rubusoside ... Rebaudioside E, Rebaudioside E2, Rebaudioside E4, Rebaudioside E6, Rebaudioside E3, Rebaudioside D, Rebaudioside I, Rebaudioside AM, Rebaudioside D7, Rebaudioside M, Rebaudioside M4, Rebaudioside 1a, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1b, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1f, Rebaudioside 1g, Rebaudioside 1c, Rebaudioside 1d, Rebaudioside 1e, Rebaudioside 1c ... Rebaudioside 1h, Rebaudioside 1i, Rebaudioside 1j, Rebaudioside 1k, Rebaudioside 1l, R...
Claims
1. Steviol glycosides I-XL having the formula: 【Chemistry 1】 (wherein the R1 and R2 carbohydrates are defined in the table below); 【Table 1-1】 【Table 1-2】 【Table 1-3】 【Table 1-4】 【Table 1-5】 【Table 1-6】 【Table 1-7】 【Table 1-8】 【Table 1-9】 【Table 1-10】 【Table 1-11】 【Table 1-12】 【Table 1-13】 【Table 1-14】
2. 10. A method for producing at least one steviol glycoside according to claim 1, comprising: a. providing a starting composition comprising an organic compound having at least one carbon atom; b. Providing an enzyme preparation or a microorganism containing at least one enzyme selected from steviol biosynthetic enzymes, NDP-glucosyltransferases, and optionally NDP-glucose recycling enzymes; c. Contacting the enzyme preparation or microorganism with a medium containing the starting composition to produce a medium containing at least one steviol glycoside according to claim 1. The method includes:
3. 10. A method for producing at least one steviol glycoside according to claim 1, comprising: a. providing a starting composition comprising an organic compound having at least one carbon atom; b. Providing a biocatalyst comprising at least one enzyme selected from steviol biosynthesis enzymes, NDP-glucosyltransferases, and optionally NDP-glucose recycling enzymes; c. Contacting the biocatalyst with a medium containing the starting composition to produce a medium containing at least one steviol glycoside according to claim 1. The method includes:
4. d. The method of claim 2 or 3, further comprising separating the at least one steviol glycoside of claim 1 from the culture medium to obtain a highly purified composition of at least one steviol glycoside of claim 1.
5. 5. The method of claims 2, 3 or 4, wherein the starting composition is selected from the group consisting of steviol, steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, other steviol glycosides, polyols, carbohydrates, and combinations thereof.
6. 3. The method of claim 2, wherein the microorganism is selected from the group consisting of E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., and Yarrowia sp.
7. 4. The method of claim 3, wherein the biocatalyst is an enzyme or a cell containing one or more enzymes capable of converting the starting composition into at least one steviol glycoside of claim 1.
8. The enzymes include mevalonate (MVA) pathway enzymes, 2-C-methyl-D-erythritol-4-phosphate pathway (MEP / DOXP) enzymes, geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), and D-1-deoxyxylulose 5-phosphate synthase (DXR). ), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (HD R), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase, UGT74G1, UGT85C2, UGT91D2, EUGT11, UGTSl2, UGT76G1, UGlyT91C1 or greater than 85% amino acid sequence identity, greater than 86% amino acid sequence identity, greater than 87% amino acid sequence identity, greater than 88% amino acid sequence identity 3. The method of claim 2, wherein the amino acid sequence is selected from the group consisting of a mutant thereof having greater than 89% amino acid sequence identity, greater than 90% amino acid sequence identity, greater than 91% amino acid sequence identity, greater than 92% amino acid sequence identity, greater than 93% amino acid sequence identity, greater than 94% amino acid sequence identity, greater than 95% amino acid sequence identity, greater than 96% amino acid sequence identity, greater than 97% amino acid sequence identity, greater than 98% amino acid sequence identity, or greater than 99% amino acid sequence identity.
9. 5. The method of claim 4, wherein the content of at least one steviol glycoside in the highly purified composition of at least one steviol glycoside described in claim 1 is greater than about 95% by weight on a dry weight basis.
10. 13. A consumer product comprising at least one steviol glycoside according to claim 1, said consumer product being selected from the group consisting of a food product, a beverage, a pharmaceutical composition, a tobacco product, a nutritional composition, an oral hygiene composition, and a cosmetic composition.
11. 11. The consumer product of claim 10, wherein the product is selected from the group consisting of beverages, natural juices, soft drinks, carbonated soft drinks, diet drinks, zero calorie beverages, low calorie beverages and foods, yogurt drinks, instant juices, instant coffee, powdered instant beverages, canned products, syrups, fermented soybean paste, soy sauce, vinegar, dressings, mayonnaise, ketchup, curry, soup, stock powder, powdered soy sauce, powdered vinegar, biscuits, rice crackers, crackers, bread, chocolate, caramel, candy, chewing gum, jelly, pudding, preserved fruits and vegetables, fresh cream, jams, marmalades, flower paste, milk powder, ice cream, sorbet, bottled vegetables and fruits, canned boiled beans, meat and foods boiled in sweet sauce, agricultural products, seafood, ham, sausages, fish ham, fish sausages, fish paste, fried fish products, dried seafood, frozen foods, preserved seaweed, preserved meat, tobacco and medicines.
12. 11. The consumer product of claim 10, further comprising at least one additive selected from the group consisting of carbohydrates, polyols, amino acids and their corresponding salts, polyamino acids and their corresponding salts, sugar acids and their corresponding salts, nucleotides, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, caffeine, flavoring agents and flavoring ingredients, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers, and combinations thereof.
13. 11. The consumer product of claim 10, further comprising at least one functional ingredient selected from the group consisting of saponins, antioxidants, dietary fiber sources, fatty acids, vitamins, glucosamine, minerals, preservatives, hydrating agents, probiotics, prebiotics, weight control agents, osteoporosis management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, phytosterols, and combinations thereof.
14. Steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside B, dulcoside C, dulcoside D, stevioside, stevioside A, stevioside B, stevioside C, stevioside D, stevioside E, stevioside E2, stevioside F, stevioside G, stevioside H, rebaudioside A, rebaudioside A2, rebaudioside A3, rebaudioside Rebaudioside A4, Rebaudioside B, Rebaudioside B2, Rebaudioside C, Rebaudioside C2, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside D, Rebaudioside D2, Rebaudioside D3, Rebaudioside D4, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside E, Rebaudioside E2, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside F, Rebaudioside Rebaudioside F2, Rebaudioside F3, Rebaudioside G, Rebaudioside H, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside I, Rebaudioside I2, Rebaudioside I3, Rebaudioside J, Rebaudioside K, Rebaudioside K2, Rebaudioside KA, Rebaudioside L, Rebaudioside M, Rebaudioside M2, Rebaudioside M3, Rebaudioside N, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudio Rebaudioside O, Rebaudioside O2, Rebaudioside O3, Rebaudioside O4, Rebaudioside Q, Rebaudioside Q2, Rebaudioside Q3, Rebaudioside R, Rebaudioside S, Rebaudioside T, Rebaudioside T1, Rebaudioside U, Rebaudioside U2, Rebaudioside V, Rebaudioside V2, Rebaudioside V3, Rebaudioside W, Rebaudioside W2, Rebaudioside W3, Rebaudioside Y, Rebaudioside Z1, Rebaudioside Z2, Rebaudioside AM, SvG7, NSF-02, Mogroside V, Sylatose, Luo Han Guo, Allulose, D-Allose,D-tagatose, erythritol, brazzein, neohesperidin dihydrochalcone, glycyrrhizinic acid and its salts, thaumatin, perillartine, pernandulcin, mukuroziosides, bayunoside, phlomisoside I, dimethyl-hexahydrofluorene-dicarboxylic acid, abrusosides, periandrin, carnosiflosides, cyclocaryoside, pterocaryoside, polypodoside A, brazilin, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, dihydroflavonol, dihydro loquercetin-3-acetate, neoastilibin, trans-cinnamaldehyde, monatin and its salts, serigeain A, hematoxylin, monellin, osladin, pterocaryoside A, pterocaryoside B, mabinlin, pentasine, miraculin, curculin, neoculin, chlorogenic acid, cynarin, siamenoside, sucralose, acesulfame potassium, aspartame, alitame, saccharin, cyclamate, neotame, dulcin, suosan, advantame, gymnemic acid, phozulcine, ziziphin, Lactisol, glutamate, aspartic acid, glycine, alanine, threonine, proline, serine, lysine, tryptophan, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolysates, polyglycitols, sugar alcohols sugars, L-sugars, L-sorbose, L-arabinose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, xylose, lyxose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, talose, erythrulose, xylulose, cellobiose,Amylopectin, glucosamine, mannosamine, glucuronic acid, gluconic acid, gluconolactone, abequose, galactosamine, sugar beet oligosaccharides, isomalto-oligosaccharides (isomaltose, isomaltotriose, panose, etc.), xylo-oligosaccharides (xylotriose, xylobiose, etc.), xylo-terminal oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose, etc.), nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose, etc.), maltotetraose, ...
11. The consumer product of claim 10, further comprising a compound selected from the group consisting of maltotolaol, maltotriol, malto-oligosaccharides (such as maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, etc.), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, isomerized liquid sugars such as high fructose corn syrups, coupling sugars, soybean oligosaccharides, D-psicose, D-ribose, L-glucose, L-fucose, D-turanose, D-leucrose.
15. 1. A method for enhancing the sweetness of a beverage or food containing a sweetener, comprising: a. providing a beverage or food product containing a sweetener; b. Adding a sweetness enhancer comprising at least one steviol glycoside according to claim 1, wherein the at least one steviol glycoside according to claim 1 is present at a concentration at or below the sweetness perception threshold. The method includes:
16. 1. A method for modifying the flavor of a beverage or food product, comprising: a. providing a beverage or food; b. Adding a composition comprising at least one steviol glycoside according to claim 1. The method includes:
17. 1. A method for suppressing air bubbles in a beverage or food product, comprising: a. providing a beverage or food; b. Adding an antifoaming agent comprising at least one steviol glycoside according to claim 1. The method includes:
